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ABSTRACT
Self-Compassion and Physical Health-Related Quality of Life in Cancer: Mediating Effects of
Control Beliefs and Treatment Adherence
by
Morgan Kate Treaster
Among the 14 million persons living in the United States with current or remitted cancer, poor
physical health-related quality of life (HRQL) is a significant concern. However, selfcompassion (i.e., common humanity, mindfulness, self-kindness) may be a protective factor,
either directly or indirectly, by allowing for a sense of empowerment and control over illness,
and in turn, facilitating engagement in treatment and positive perceptions of health. Serial
mediation analyses among persons living with current (n = 67) or remitted (n = 168) cancer lend
support for a positive, direct association between self-compassion and physical HRQL, as well as
indirect effects via internal perceived control and, to a lesser degree, treatment adherence. Mixed
findings, especially among cancer patients, highlight limitations of resiliency traits while also
supporting the notion that self-compassion interventions (e.g., Mindful Self-Compassion
Training) may have positive implications for health-related control beliefs, behaviors, and
quality of life in the cancer population.
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CHAPTER 1
INTRODUCTION
By the year 2024, approximately 19 million persons in the United States (U.S.) will be
living with a history of cancer, making it one of the most prevalent chronic illnesses in the
country (DeSantis et al., 2014). Symptomatically, cancer survivors, and individuals currently
undergoing treatment, frequently report poor physical HRQL, including deleterious
physiological changes and declines in the functioning of bodily systems, making it difficult to
complete daily activities of living (e.g., cooking, cleaning; Hewitt, Rowland, & Yancik, 2003;
Stein, Syrjala, & Andrykowski, 2008). Yet, despite such difficulties, not all individuals report
poor physical HRQL during their cancer experience or recovery, perhaps due to the presence of
individual-level protective characteristics.
One potential protective factor, self-compassion, is comprised of the elements of
common humanity, mindfulness, and self-kindness, and is associated with better physical health
outcomes (Neff, 2003). This effect may occur directly, as self-compassion encourages a sense of
connectedness with others in similar situations, may help to decrease risk for negative emotional
responses to illness-related challenges, and increase the probability of positive thoughts and
feelings toward the self during a health crisis (Sirois, Kitner, & Hirsch, 2015; Sirois & Rowse,
2016; Terry & Leary, 2011). Self-compassion may also be associated with perceptions of better
physical HRQL indirectly, via its impact on cognitive, emotional and behavioral processes,
including the development and maintenance of control beliefs related to illness and engagement
in adaptive health behaviors.
Control beliefs, or the extent to which individuals perceive control over their illness and
general health, is one potential mediating variable of this linkage. By recognizing that others are
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currently facing similar illness-related challenges (e.g., cancer diagnosis and treatment),
attending to both positive and negative emotions related to the illness experience, and directing
kind thoughts or actions toward the self, individuals may perceive greater perceptions of control
and efficacy regarding their illness and its treatment (Barnard & Curry, 2011; Neff, Rude, &
Kirkpatrick, 2007; Reyes, 2012). In turn, acting in accordance with those beliefs of control,
patients may more-readily engage in proactive health behaviors (Pertl et al., 2010); for instance,
treatment adherence, another potential mediating variable, may be viewed as a potential
mechanism of change, whereby the patient can exercise control over their illness (Atkins &
Fallowfield, 2006) and, in turn, may be more likely to experience better perceptions of wellbeing and physical HRQL (Denois et al., 2011).
This is the focus of our current study, which is intended to contribute to the existing
literature focused on the interrelations of these variables, within the cancer population. In the
context of chronic illness, HRQL may be influenced by many cognitive, emotional and
behavioral factors, including ability to engage in self-compassion, sense of perceived control,
and adherence to treatment recommendations, respectively. In the following sections, we provide
a review of the extant literature on these variables, and their interrelations, across disease
populations. Yet, to our knowledge, no previous research has examined the serial relations
between our proposed variables, nor among persons living with a past or present cancer
diagnosis, as we do in the current study.
Cancer: Overview and Epidemiology
Cancer is a chronic disease characterized by the uncontrollable growth and spread of
abnormal cells, and the site of development (e.g., breast, prostate, lung) indicates the type of
cancer (American Cancer Society [ACS], 2016). Cancer patients report a variety of symptoms
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related to their illness. For instance, many report experiences of “chemo brain” which refers to
disruptions in memory, attention, and mental processing speed (Siegel et al., 2012). Chronic
fatigue is another common problem, reported by up to 70% of cancer patients, especially when
undergoing chemotherapy or radiation (Dimeo, 2001). Others report bone, joint, and soft tissue
problems including bone fractures, atrophy, and deformity as well as osteoporosis and osteopenia
(Ganz, 2006; Siegel et al., 2012). Impaired cardiovascular functioning (e.g., accelerated
atherosclerosis, congestive heart failure) is yet another commonly cited complaint (American
Association of Clinical Oncology [ASCO], 2017), as are disruptions to the endocrine system
(e.g., hormone deficiencies, infertility), especially when treatment of cancer requires the removal
of reproductive organs (Marijnen et al., 2005; Siegel et al., 2012). The gastrointestinal system
may also be adversely affected (e.g., nausea, digestive problems), leading to changes in eating
habits and weight gains or losses (Fodeh et al., 2013). Related to the bodily processing of
nutrients, some persons living with cancer also report disruptions to kidney and bowel
functioning (Marijnen et al., 2005; Miller et al., 2005). Finally, impaired immune functioning,
including low blood cell counts, is a concern among cancer patients, as it increases risk for the
development of additional acute and chronic conditions during treatment and the years following
a cancer-free diagnosis (Ganz, 2006; Stein et al., 2008).
Treatment of cancer and related symptoms varies relative to the type or stage of cancer as
well as individual preferences, and some treatment options may be more desirable or effective
than others (DeSantis et al., 2014). Despite this variation, there are several common treatments
utilized by cancer patients to rid the body of cancer cells (ACS, 2017). Chemotherapy is a
medication that can be administered in many ways (e.g., oral, intravenous, injection), and it is
designed to stop the growth of rapidly multiplying cancer cells, though it may kill healthy cells
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as well. On the other hand, targeted drug therapy attacks the parts of cancer cells that make them
different from healthy ones, and the targeted parts of the cells vary across cancer types (e.g.,
epidermal growth factor receptor in colorectal cancer; BRAF gene in melanoma). Radiation
therapy, which uses high external or internal beam radiation, is another treatment technique, with
several types of radiation treatments available, such as three-dimensional conformal radiation
therapy (3D-CRT) or brachytherapy. Other individuals rely on immunotherapy which involves
strengthening the body’s natural immune system, allowing it to recognize and destroy the cancer
cells. Individuals may take an oral drug (e.g., immune checkpoint inhibitors, monoclonal
antibodies), or may undergo a moderate surgical procedure such as t-cell therapy. Finally, more
invasive surgical procedures may be necessary, such as a modified radical mastectomy for breast
cancer or radical prostatectomy for prostate cancer. In addition to illness-based symptoms,
cancer patients and survivors report a multitude of immediate (e.g., nausea, anemia) and delayed
onset (e.g., bone atrophy, memory loss) treatment-related side effects, which may exacerbate
existing symptoms and lead to poor health across the lifespan (Stein et al., 2008).
Epidemiology: Rates of Cancer, Death, and Survival
Cancer has a significant impact on physical health and well-being and, in recent years,
the number of individuals living with cancer has risen steadily. Globally, cancer prevalence rates
increased nearly 50% between 2003 and 2013 (Crocetti et al., 2013). East Asia has the highest
five-year prevalence rate, equating to nearly seven million persons, and North America has the
second highest rate, with an estimated four million individuals (Bray, Ren, Masuyer, & Ferlay,
2013). In the U.S., nearly 38.5% of individuals will receive a cancer diagnosis at some point in
their lifetime (National Cancer Institute [NCI], 2017). Diagnostic estimates for 2017, for
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instance, indicated that 1,688,780 new cases would appear, and that 70% of those cases would
occur in persons between 55 and 84 years old (NCI, 2017).
Incidence rates for specific types of cancer vary, based on individual, sociocultural and
environmental factors. Breast cancer, however, is the most common diagnosis globally, followed
by prostate and colorectal cancers, and these subtypes account for over two-fifths of diagnosable
cancers (Bray et al., 2013). In the U.S., specifically, incidence rates are highest for breast cancer
among women, and prostate cancer in men (Jemal et al., 2005). For both men and women, lung
and bronchus cancers are the second most commonly diagnosed, followed by colon and rectal
cancers (Jemal et al., 2005).
Upon examination of demographic variables, sex differences also emerge. In the U.S.,
lifetime risk for cancer is 42% for men, compared to 38% for women (ACS, 2016). Additionally,
breast cancer represents more than 40% of all diagnosed forms of cancer in women, followed by
uterine corpus (8%) and rectal cancers (8%; Crocetti et al., 2013; DeSantis et al., 2014). For
males, the top three cancer types include prostate (43%), colorectal (9%), and melanoma (8%;
DeSantis et al., 2014). Age differences in the rate of new diagnoses have also been reported. In
2010, among persons 50 – 64 years old, there were 804.8 new cancer diagnoses, per 100,000
individuals, relative to 152.3 new diagnoses among persons 20 – 49 years old (Jane, Singh, King,
Wilson, & Ryerson, 2014). Median ages for diagnosis range from 51 (thyroid cancer) to 73
(bladder cancer) years old, and it has been reported that 86% of newly diagnosed cancer patients
are 50 years or older, highlighting the heightened cancer risk associated with aging (ACS, 2016;
DeSantis et al., 2014). Finally, there are racial and ethnic variations in cancer diagnoses; for men,
overall cancer diagnoses are highest among Blacks, followed by Whites, Latinos, Asian/Pacific
Islanders, and American Indian/Alaska Natives and, for women, overall incidence rates are
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highest among Whites, followed by Blacks, Latinas, Asian/Pacific Islanders, and American
Indian/Alaska Natives (Centers for Disease Control and Prevention [CDC], 2016b).
Given such disparities, and rising overall prevalence rates, it is not surprising that cancer
is the second most common cause of death in the U.S. In 2016, an estimated 595,690 Americans
died from cancer, equating to approximately 1,630 deaths per day (ACS, 2016) and, in 2017, it
was estimated that there would be 600,920 cancer-related deaths, with 72 as a median age of
death (NCI, 2017). For men, the leading types of cancer that cause death are lung and bronchus,
prostate, and colorectal cancer, and the findings are similar for women, with the exception that
breast cancer replaces prostate cancer as the leading contributor to mortality (CDC, 2016a;
Siegel, Ma, Zou, & Jemal, 2014).
Significant advancements have been made, however, in terms of early detection and
treatment, leading to improvements in cancer survival rates and a growing number of individuals
living with a cancer history (de Moor et al., 2013). As of January 1, 2014, an estimated 14
million persons in the U.S. had a cancer history, which is a three-fold increase relative to 1975,
and this number is projected to increase to nearly 19 million persons over the next decade
(DeSantis et al., 2014; de Moor et al., 2013). According to the NCI (2014), five-year survival
rates for the top twelve types of cancer are 89.7% (breast-females only), 18.3% (lung and
bronchus), 98.6% (prostate-males only), 64.9% (colon and rectum), 91.7% (melanoma), 77.3%
(bladder), 71% (non-Hodgkin lymphoma), 74.1% (kidney and renal), 60.6% (leukemia), 81.3%
(endometrial-females only), 98.2% (thyroid), and 8.2% (pancreas), and these rates are reflected
in the type of cancer history endorsed by survivors (Gilbert, Miller, Hollenbeck, Montie, & Wei,
2008). Additionally, individuals are living much longer despite a cancer history; 64% of
individuals have survived five or more years, which is a 37% increase since 1975, and 40% have
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survived 10 or more years (de Moor et al., 2013). As such, there are more persons than ever
before living with a cancer history in the U.S., and greater attention has been given to
survivorship care in the literature, including maintenance of general health, coping with late and
long-term treatment-related side effects, and enhancement of HRQL (Gilbert et al., 2008).
Physical Health-Related Quality of Life (HRQL)
HRQL refers to the subjective assessment of well-being across multiple life domains,
including physical, mental, emotional, and social functioning (Revicki et al., 2000; Wilson &
Cleary, 1995). In the general population, HRQL encompasses factors including the presence of
positive emotions and moods (e.g., happiness), the absence of negative emotions (e.g., anxiety),
financial stability, life satisfaction, meaningful social relationships, and engagement in fulfilling
life activities (CDC, 2016c). For individuals living with a chronic illness, assessments of HRQL
are often influenced by the perceived impact of disease and treatment, across life domains
(Revicki et al., 2000). Physical HRQL encompasses the frequency, severity, and types of illness
symptoms (e.g., pain, fatigue) as well as the extent to which those symptoms may impact one’s
daily physical functioning (e.g., walking) or interfere with activities of daily living (e.g.,
bathing). Often, this domain overlaps with social functioning, as physical symptoms may
interfere with one’s ability to engage in activities with friends or family. The domains of mental
and emotional health are often intertwined as well, and they provide an indication of the extent to
which individuals believe they can control their thoughts (e.g., perceived control, decisionmaking) and feelings (e.g., sadness, worry, excitement) across various types of situations,
including health-related experiences.
As a construct, HRQL goes beyond biological or physiological indicators of health and
well-being (e.g., bloodwork), by accounting for individual-level factors, such as patient values

16

(e.g., family, outdoor hobbies) and preferences (e.g., treatment plan), which may influence
perceptions of specific symptoms or the disease experience, as a whole (Cella & Stone, 2015;
Wilson & Clearly, 1995). In fact, subjective HRQL assessments have emerged as more powerful
predictors of morbidity and mortality relative to objective measures of well-being and, thus,
assessment of such internal factors, including a person’s unique illness experiences and
interpretations, may help to better understand their perceived health status, well-being, and
overall adjustment to a chronic illness (Cella & Stone, 2015).
Applied to individuals living with a past or present cancer diagnosis, HRQL often focuses
on how disease symptoms and adverse treatment effects deleteriously impact daily physical
functioning, mental health, and participation in the social sphere (e.g., public places, recreational
activities with friends and family; Cella & Stone, 2015). In the current study, we focus
specifically on physical HRQL, given its prevalence in, and importance to, the cancer
population. As an example, cancer survivors (N = 4,878), ranging from less than two years to
more than twenty years since their cancer diagnosis, reported poorer physical health and
disability later in life, at a rate two to five times worse than the general population (Hewitt et al.,
2003). In another study of cancer patients (n = 1,822), compared to individuals with no history
of cancer (n = 24,804), 25% of cancer patients reported poor physical HRQL compared to a
control group (10%), and predictors of poor HRQL included younger age, lower socioeconomic
status, and a greater number of non-cancer physical comorbidities (e.g., diabetes, hypertension,
arthritis; Weaver et al., 2012), which are also a consequence of cancer survivorship (Keating,
Nørredam, Landrum, Huskamp, & Meara, 2005). Similarly, in a sample of older (65+ years old)
male prostate cancer survivors (n = 445), as compared to non-cancer controls, individuals with a
cancer history reported worse overall general health, in addition to the presence of illness
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symptoms such as muscle weakness or weight gain (Reeve et al., 2012). Finally, among samples
of female breast cancer patients, physical HRQL was lower in a subgroup of patients who
reported less engagement in physical activities or regular exercise, illustrating a potential linkage
between HRQL and activities requiring physical exertion (Alfano et al., 2007; Kendall, MagueGiangreco, Carpeter, Ganz, & Bernstein, 2005).
Indeed, for many individuals living with a cancer history, disease symptoms and
treatment-related side effects may be associated with physical performance limitations or
restrictions across various life domains, including self-care (e.g., bathing), home management
(e.g., cleaning), leisure roles (e.g., going to the movies), and employment (Ness, Wall, Oakes,
Robison, Gurney, 2006). For example, in a study of long-term cancer survivors (N = 968),
participants reported an increased number of days spent out of daily roles (e.g., housework,
employment) following their diagnosis (Eakin et al., 2006). Other functional limitations have
been reported among individuals living with a history of gastrointestinal-related cancers or
cancer of the head or neck, including difficulties associated with eating, dressing, walking,
bathing, and toileting (Fodeh et al., 2013). Pain may also contribute to functionality; for instance,
in a sample of nurses living with a history of breast cancer, participants reported a loss of
physical role functioning due to chronic pain (Kroenke et al., 2004). Finally, the interrelation
between aging and cancer history is important for understanding functional limitations. Among
older male prostate cancer survivors, age 65 years and older (n = 445), cancer history, and
receipt of hormone or radiation therapy, was associated with a greater number of physical role
limitations relative to non-cancer controls (Reeve et al., 2012).
Given the subjective nature of HRQL assessment, findings from the extant literature are
likely influenced by an array of individual-level factors. Yet, such intra-personal factors are often
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overlooked, or unaccounted for, in HRQL studies. In our current study, we examined several
individual-level factors that might influence perceived physical HRQL in persons with cancer,
beginning with a discussion of the potential effects of self-compassion on health and well-being.
Self-Compassion
Self-compassion, which is a personal and adaptive cognitive-emotional-behavioral
resource, has emerged in recent research as a robust contributor to adaptive health behaviors and
physical well-being, including in the context of chronic illness, broadly, and cancer, specifically
(Gillanders, Sinclair, MacLean, & Jardine, 2015; Sirois & Rowse, 2016).
Rooted in Buddhist tradition, self-compassion emerges during or following an instance of
suffering, which can exist in many forms including distressing events (e.g., diagnosis with
chronic illness), deleterious physical functioning (e.g., pain, impairment), or negative emotional
reactions (e.g., guilt, fear, perceived loss of control; Reyes, 2012). Self-compassion is comprised
of three elements, including common humanity, mindfulness, and self-kindness, which are not
mutually exclusive but, rather, interact with one another to facilitate a self-compassionate frame
of mind during times of hardship (Germer & Neff, 2013).
Specifically, the element of common humanity encourages individuals to acknowledge
that suffering, failure, and perceived inadequacies are part of the human condition (Neff, 2003).
Common humanity allows the self to be fully human, which necessitates acceptance of personal
imperfections and limitations (Barnard & Curry, 2011), including illness and impairment.
Acceptance of a sense of common humanity involves acknowledging the interconnectedness and
equality of everyone in society (Barnard & Curry, 2011; Neff, 2003), and is in sharp opposition
to feelings of isolation or the notion that struggles and failures are something experienced only
by the self (Germer & Neff, 2013). Thus, common humanity provides individuals with a sense of
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belonging and comfort during times when tangible or emotional support is needed the most
(Reyes, 2012).
Mindfulness involves awareness, attention, and acceptance of the present moment,
including thoughts, feelings, behaviors, and the environment, as a whole (Barnard & Curry,
2011; Neff, 2003). Mindfulness is the opposite of overidentification, which involves tunnel
vision and focusing strictly on negative emotions, feelings, or behaviors, including a
magnification of failures and rumination on weaknesses or limitations (Barnard & Curry, 2011).
Mindfulness is also contrary to intentional avoidance or the suppression of painful thoughts and
emotions; rather than ignoring negative feelings and allowing them to intensify with the passage
of time, individuals are encouraged to openly acknowledge and process them, in the moment,
thereby facilitating movement toward more-adaptive cognitive-emotional responses (Barnard &
Curry, 2011; Germer & Neff, 2013). By recognizing the impermanence of all emotions and
situations, as well as acknowledging that others have experienced similar feelings in equivalent
circumstances (i.e., common humanity), it is possible to move forward from instances of
suffering (Reyes, 2012).
Lastly, there is self-kindness, defined as the extension of warmth, care, and understanding
toward the self during times of suffering, failure, or perceived inadequacy (Germer & Neff,
2013; Reyes, 2012). Self-kindness is the opposite of self-judgment; individuals must let go of
regrets, disappointments, and thoughts about the way things “could have been,” instead choosing
to acknowledge problems and shortcomings without assuming personal guilt or punishing the
self (Germer & Neff, 2013; Reyes, 2012). By extending gentleness and patience toward the self,
while also being mindful and recognizing common humanity, individuals are more likely to
experience positive overall well-being and health (Neff, 2003).
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Self-Compassion and Overall Well-Being
Indeed, in past research, self-compassion has demonstrated positive associations with
healthy emotional states, including happiness, positive affect, and life satisfaction (Neff et al.,
2007), and it has been linked to cognitive factors such as an optimistic state of mind (Neff et al.,
2007). Furthermore, self-compassion has been linked to agreeableness and extraversion, both of
which may be particularly adaptive in the context of chronic illness by encouraging social
connectedness (i.e., social support of friends and family) or compliance with a healthcare
provider’s recommendations (e.g., regular exercise; Neff et al., 2007). Individuals higher in selfcompassion also tend to utilize problem-focused coping strategies when faced with stressful
situations (e.g., diagnosis of a chronic illness), such as cognitive reframing (e.g., finding benefits
of diagnosis) or seeking out social support and external resources that may increase likelihood of
better adjustment (Neff, 2003; Sirois & Rowse, 2016).
On the other hand, in both the general population and clinical samples, a negative relation
exists between self-compassion and neuroticism, depression, anxiety, and psychological distress
(Neff, 2003; Neff et al., 2007). Negative emotions or cognitions may interfere with one’s ability
to cope in proactive ways and, indeed, persons low in self-compassion tend to engage in
maladaptive coping strategies such as self-blame, escape-avoidance coping, and cognitivebehavioral disengagement from stressors (Sirois & Rowse, 2016). Individuals may try to ignore
symptoms, or even their overall diagnosis and, in other cases, may direct harsh thoughts toward
the self (e.g., self-blame for the disease), as ways of coping with their distress. Although such
responses may alleviate negative feelings temporarily, such coping strategies are often
detrimental to long-term adjustment to illness or the recovery process.
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Given its implications for, and associations with, adaptive cognitive, emotional and
behavioral processes, self-compassion may be viewed as a coping resource, held in reserve, that
emerges and may be accessed during times of distress. To the extent that individuals with
chronic illness can draw upon and engage in self-compassion, they may be more likely to
experience better physical HRQL.
Self-Compassion in the Context of Chronic Illness
Individuals living with a chronic illness, including cancer, may draw upon selfcompassion broadly, but also its specific sub-components, at many stages of the disease process.
By recognizing that others have been similarly diagnosed and also face illness-related challenges
(e.g., the common humanity of symptoms, treatment side effects), individuals are less likely to
feel alone in their suffering and, consequently, may experience better emotional responses to
their illness and may respond to their illness in more proactive ways, such as seeking out the
support of others (e.g., online or in-person support groups) in the pursuit of health-related goals
(e.g., remission, improved HRQL; Sirois, Molnar, & Hirsch, 2015; Terry & Leary, 2011). In the
context of illness, the component of mindfulness may help temper negative emotional responses
to relapses or treatment-related frustrations (e.g., functional impairment, goal thwarting), which
may or may not be under one’s control, thereby increasing probability of a balanced and
objective view of the illness experience (Sirois & Rowse, 2016). Mindfulness activities
associated with an altered perspective or emotional experience include progressive muscle
relaxation, deep breathing exercises, or nature walks, as each of these activities helps to
physiologically calm the entire body and promote clearer thought processes.
The final component of self-compassion, kindness toward the self, may help to counteract
negative, illness-based views, such as attributing the cause of illness to one’s personal behaviors
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(e.g., smoking), criticizing the self for a failure to adhere to treatment recommendations, or selfcritique regarding functional limitations (Terry & Leary, 2011). Examples include mentally or
verbally repeating statements of positive self-talk (e.g., “I am doing the best I can right now”) or
partaking in self-care activities (e.g., spa day). Such actions are sharply opposed to thoughts or
feelings one may have about the self, and as such, may help to shift how an individual treats the
self in the context of a chronic illness.
For persons living with potentially chronic conditions, such as cancer, engagement in one
or more of these self-compassion exercises may be particularly useful when faced with an illness
diagnosis and, further, the ability to partake in such exercises may increase probability of
improvements in perceived HRQL. Regarding mechanism of action, self-compassion may have a
direct effect on HRQL, but it is also possible that other cognitive, emotional, or behavioral
processes could play an indirect role in the linkage of these variables. Given the aforementioned
positive associations of self-compassion in relation to psychological and emotional well-being,
we will now discuss the existing literature documenting the association of self-compassion to
health, health behaviors and HRQL among persons living with chronic conditions, including
individuals with a past or present cancer diagnosis.
Direct effects of self-compassion on physical HRQL. In both the general population
and clinical samples, self-compassion appears to have a direct, positive association with health.
For example, in a sample of individuals with a variety of medical conditions, greater selfcompassion was associated with less perceived impact of disease across life domains, including
performance at home, work, or school, enjoyment of social activities, and interpersonal
relationships (Terry, Leary, Mehta, & Henderson, 2013). In another study, of persons living
without chronic conditions, self-compassion was, nonetheless, associated with fewer
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physiological symptoms that are often indicative of a pending health problem or illness (e.g.,
fatigue, pain; Dunne, Sheffield, & Chilcot, 2016).
Similar beneficial patterns of associations exist between self-compassion and health
outcomes, in persons with chronic illness. For example, among persons living with Celiac
disease, self-compassion was a significant predictor of HRQL; individuals higher in selfcompassion reported fewer illness-related physical limitations in completing activities of daily
living (e.g., eating with coworkers, extended travel; Dowd & Jung, 2017). In another study, of
obese patients living with chronic musculoskeletal pain, self-compassion was related to less
functional impairment (Wren et al., 2012). Finally, in a sample of persons living with multiple
types of cancer (N = 106), self-compassion was predictive of better physical (e.g., pain, energy
levels, nausea) and functional (e.g., housework, employment, sleep, leisure activities) well-being
(Gillanders et al., 2015).
These studies illustrate basic positive associations between perceptions of HRQL and
self-compassion. Yet, self-compassion, in isolation, may not directly lead to better HRQL;
rather, other mechanisms may be involved in the relationship of self-compassion and physical
HRQL among persons living with chronic health conditions.
Indirect effects of self-compassion on physical HRQL. Several linking mechanisms
between self-compassion and HRQL have been proposed, including cognitive, emotional,
motivational and behavioral factors. To begin, self-compassion has been linked to changes in
thought processes or cognitions. As one example, among persons living with chronic pain, selfcompassion was associated with fewer catastrophic responses to physical symptoms (e.g.,
thoughts of never-ending pain, beliefs of not being able to live in chronic pain any longer), better
psychological adjustment, and lower scores for pain-related disability (Wren et al., 2012).
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Self-compassion has also been associated with physical HRQL via its contributions to
better emotional health. In the context of high self-compassion, individuals living in chronic pain
were less likely to report negative affect, including feelings of irritability, distress, shame, guilt,
and fear, and in turn, lower levels of pain-related disability (Wren et al., 2012). A treatment
study further illustrated how self-compassion may reduce risk for psychological distress and
increase probability of better HRQL; intervention-induced self-compassion was associated with
physiological changes, including a decrease in stress-related inflammation, lower sympathetic
nervous system reactivity, and improved parasympathetic nervous system reactivity (Homan &
Sirois, 2017; Sirois & Rowse, 2016). Finally, in terms of emotional processes, self-compassion
may reduce risk for illness-related anxiety and depression, as illustrated in studies of breast
cancer patients and persons with disordered eating patterns (Kelly, Vimalakanthan, & Carter,
2014; Przezdziecki et al., 2013).
Motivation to set and attain goals, including the volitional behaviors often needed to
achieve goals, may also be subject to the influence of self-compassion. Broadly, self-compassion
may steer individuals away from avoidant coping styles in favor of problem-focused (e.g., goal
setting, use of instrumental social support) or active emotional coping (e.g., acceptance, positive
reframing), as demonstrated in a study of cancer patients (Gillanders et al., 2015). More
specifically, self-compassion may be predictive of greater intrinsic motivation, as well as
proactive and goal-oriented behaviors, focused on improvement of well-being, health, or illness.
For example, among those with chronic illness, self-compassion was predictive of higher
motivation for self-kindness (e.g., “I think I should do something nice for myself”) and a
proactive health focus characterized by a perceived ability to actively combat or control one’s
health (e.g., “If I notice something about my health that I don’t like, I work to fix it”) which, in
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turn, were linked to better HRQL (Terry et al., 2013). In another study of young women who
self-reported engagement in regular exercise, self-compassion was related to a greater intrinsic,
rather than extrinsic, desire to exercise, suggesting the potential role of self-compassion in the
encouragement and facilitation of adaptive health-related behaviors (Magnus, Kowalski, &
McHugh, 2010). Importantly, this same pattern exists for disease samples; for example, in
persons living with HIV, self-compassion was predictive of engagement in proactive health
activities, including fewer risky sexual behaviors, higher rates of treatment adherence, a greater
tendency to seek medical-related information, and higher utilization of the health care system
(Brion, Leary, & Drabkin, 2014; Rose et al., 2014). Such behaviors may be reflective of a
perceived sense of control, and the belief one has about personal ability to alter health status
through engagement in proactive and adaptive health-related activities.
Finally, self-compassion may have a positive relation to proactive health behaviors by
increasing the likelihood that one perceives self-efficacy and confidence in the pursuit of healthrelated goals, perhaps via enhanced emotion regulation and self-kindness during treatment
efforts. For example, among Celiac disease patients, self-regulatory efficacy emerged as a
significant mediator in the relations between self-compassion and dietary adherence and physical
HRQL (Dowd & Jung, 2017). Similar findings emerged in a study of undergraduate students
with disordered eating patterns; self-compassion was associated with greater perceived ability to
monitor and regulate food intake, even when given unlimited access to candy (Adams & Leary,
2007). This pattern of effects suggests that, across studies, belief in personal control and efficacy,
may be predictive of engagement in activities likely to have a positive effect on current and
future health functioning and perceptions of health. It can be conceptualized, therefore, that selfcompassion, via its positive association with emotion regulation, volitional behavior, and self-
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competency, may provide chronically ill persons with a sense of control over their disease,
treatment, and general well-being (Dowd & Jung, 2017; Gillanders et al., 2015; Wren et al.,
2012).
Control Beliefs
The concept of “controllability” is rooted in Julian Rotter’s social learning theory, which
states that events or behaviors can be predicted by knowledge of how one views the situation,
including the degree to which it is under one’s own influence, assessment of capability to resolve
the situation, and outcome expectancies for resolution-oriented behaviors (De Valack & Vinck,
1996; Wallston, 1992). In the context of chronic illness, control beliefs may influence how an
individual conceptualizes, understands, and responds to a disease diagnosis and treatment
(Scharloo et al., 1998). Furthermore, individuals may perceive varying levels of control over
their symptoms, general health, or personal ability to complete treatment requirements.
As one example, persons living with a chronic illness may perceive internal control over
their illness, which refers to the belief that one has the power or ability to control their health,
their disease, or specific aspects of the illness experience (e.g., symptoms; treatment regimens;
Wallston, 2001; O’Hea et al., 2005). On the other hand, external control refers to the belief that
health is beyond one’s personal level of control, and that external factors (e.g., doctors, fate,
chance, divine being) are responsible for the course of disease or health in general (De Valck &
Vinck, 1996; Wallston, 2001).
Perceived internal and external control are often influenced by prior experiences of
positive or negative reinforcement associated with a behavior which, in turn, inform one’s views
regarding what will happen in the future when engaging in similar behaviors (i.e., outcome
expectancies; Wallston, 1992). Therefore, individuals high in perceived internal control may
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recognize that many health-related outcomes (e.g., pain, fatigue) are dependent on present
choices and actions (e.g., medication adherence, regular exercise), perhaps due to prior problemsolving successes and an awareness of the linkage between present behaviors and future health
status (Ranchor et al., 2010). As well, past health-related successes (e.g., weathered a previous
illness) that inform appraisal of current stressors as manageable (e.g., long-term cancer
treatment), may enhance sense of control and ability to cope with a current health crisis (Carver
et al., 2000).
It may be that, individuals with strong perceptions of external control have not
experienced such efficacious success related to past health behaviors and, thus, may believe that
personal actions and subsequent health outcomes are unrelated or that health goals are
unattainable (Wallston, 2002). Individuals who believe health is beyond their personal control
may also have a history of disempowering experiences, in which they felt threatened by stressors
they were unable to resolve, resulting in a lack of self-confidence and failure to believe that their
actions, including health behaviors, will be successful (Faller, Schilling, & Lang, 1995; Norton et
al., 2005). Thus, individuals with an external, rather than internal, sense of control, may perceive
current stressors as more difficult to manage and, in turn, may display passivity when attempting
to cope with a chronic health condition.
Broadly, individuals attribute health outcomes, both good and bad, to factors either
within or outside their personal locus of control, and the adaptiveness of their attributions and
perceived sense of control varies across situations. Internal control is adaptive, in the event a
specific “good” health outcome can, indeed, be attributed to personal actions, such as the linkage
of smoking cessation and a decreased risk for lung cancer, or between treatment adherence and
subsequent cancer remission (Carver et al., 2000; De Valck & Vinck, 1996). However, it can
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also be maladaptive to assume personal responsibility for situations that cannot be realistically
changed or controlled through human actions (e.g., non-responsiveness to chemotherapy
regimen), which may then lead to negative emotions, such as disappointment or distress.
Similarly, the adaptability of external control varies across situations and individuals (De
Valck & Vinck, 1996; White, Lehman, Hemphill, Mandel, & Lehman, 2006); for instance, it
may be beneficial to believe “bad” health is controlled by external factors (e.g., biology, chance),
when personal health behaviors, past and present, are not linked to the course of disease, thereby
avoiding distress. Yet, this strategy can also be maladaptive if individuals deflect responsibility
or personal control over a health outcome, whether good or bad, that can be attributed to their
actions, thereby depriving themselves of self-efficacy or credit for the exertion of control, on the
one hand, or accountability, on the other. Pragmatically, relinquishing control to external factors
may be maladaptive if one continues to engage in an unhealthy behavior (e.g., smoking) or takes
a passive approach to treatment, such as noncompliance with a medical provider’s
recommendations. Despite potential benefits and harms associated with each broad type of
control, both theory and research suggest that an internal locus of control, whereby an individual
feels able to make autonomous decisions and enact health behaviors competently, may have
more positive associations and outcomes in the context of chronic illness and HRQL (Carver et
al., 2000; Ranchor et al., 2010).
Control Beliefs and Physical HRQL
Theories of controllability have been tested empirically, with regard to physical HRQL.
Broadly speaking, in the general population, an internal locus of control is related to greater
engagement in preventative health behaviors, including routine yearly physicals, higher rates of
self-administered breast exams, attempts to cut down on the use of alcohol and cigarettes,
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dieting, voluntary exercise, and lower utilization of tanning beds by young adults (Laffrey &
Isenberg, 2003; Pertl et al., 2010; Sangeeta & Rana, 2015). Importantly, internal control is
associated with knowledge-seeking about existing health conditions (e.g., asking a doctor,
researching symptoms), geared toward understanding one’s risk for disease and how to best
manage health proactively (Laffrey & Isenberg, 2003).
Similar patterns exist in samples of persons with chronic health conditions. For instance,
in a sample of persons with diverse chronic illnesses (e.g., rheumatoid arthritis, chronic
obstructive pulmonary disease, psoriasis), a weakened sense of control (e.g., passive coping,
belief in a long illness duration) was associated with poor social and physical functioning, and
self-reported role limitations (Scharloo et al., 1998), whereas a greater sense of control (e.g.,
active coping, belief in controllability/curability of disease) was predictive of better functioning.
Controllability of disease is also important in cancer-focused research. For example,
among persons living with breast cancer, high perceived control over physical symptoms was the
strongest predictor of physical HRQL (Beckjord, Glinder, Langrock, & Compas, 2009).
Similarly, in a sample of male colorectal cancer patients, high perceived control was associated
with better self-management of disease (e.g., redressing surgical wounds without assistance),
better self-reported physical HRQL, and less severe perceptions of functional impairment (Kidd,
Hubbard, O’Carroll, & Kearney, 2009), whereas those with low perceptions on internal control
were more likely to report fatalistic beliefs regarding their health, such as the idea that treatmentrelated side effects were uncontrollable and doubt about the efficacy of self-care efforts. Finally,
in a study of middle-aged females living with late-stage cancer, perceived mastery over one’s
illness, and optimism, were negatively related to pain severity and fatigue, and those with a
greater sense of mastery were more likely to accept, and therefore transcend, their cancer
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diagnosis and treatment, and were also more likely to utilize adaptive coping strategies,
including active planning (Kurtz, Kurtz, Given, & Given, 2008).
Overall, the existing literature indicates that sense of control may be situational, may
develop from past success/failure experiences and, importantly, that it has a robust association
with health functioning. Yet, in cases where an individual’s sense of perceived control is lacking,
or is maladaptively related to HRQL, it may be possible to offset such consequences. Given the
positive association of self-compassion and cognitive-emotional functioning, it may also be
possible to utilize self-compassion strategies to increase the probability that one experiences a
sense of perceived control, with positive implications for HRQL.
Control Beliefs, Physical HRQL, and the Role of Self-Compassion
Among persons living with a chronic illness, such as cancer, the ability to engage in one
or more elements of self-compassion may be predictive of greater perceptions of internal control
and have a positive relationship with HRQL. For instance, self-kindness may have a positive
association in several ways. Among individuals who acknowledge their personal contribution to
the current illness diagnosis or experience (i.e., internal control), the extension of warmth and
empathy towards the self for past health-related indiscretions or current treatment difficulties
may reduce likelihood of self-critique and be predictive of greater motivation to engage in
proactive health behaviors (Neff, 2003). For persons who perceive little internal control over
their illness, the encouragement of actions in congruence with self-kindness (e.g., exercise) could
help to increase conscientiousness of small albeit important ways in which they can exert some
kind of control over their health or general well-being, regardless of whether or not they still
believe health is largely determined by external factors (Neff et al., 2007).
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Furthermore, the self-compassion element of mindfulness may be useful in helping
individuals attain and maintain an appropriate level of perceived control over their illness, as
mindfulness encourages acceptance and awareness of the present moment, promoting a balanced
view of emotions or situations rather than placing too much emphasis on any given part of the
experience (Barnard & Curry, 2011; Neff, 2003). For instance, mindfulness may lower the
likelihood that one holds an implausible degree of perceived control (e.g., “I do not get sick” or
“It will not happen to me”), which could be associated with ignorance of current health warning
signs or neglect of preventive or interventive treatment, and subsequent health consequences
(Ranchor et al., 2010). Additionally, mindfulness may be useful for persons who perceive a
complete loss or absence of control over their health, by grounding them in the present moment,
restoring emotional balance, and helping them to identify health-related actions that may enable
them to take control over their illness and experience better health outcomes (Brown, Byrant,
Brown, Bøi, & Judd, 2016; Gillanders et al., 2015; L’Estrange, Timulak, Kinsella, D’Alton,
2016).
Finally, within a health-promotion framework, acknowledging that others have also made
similar unhealthy decisions in the past (e.g., smoking, lack of exercise), and recognizing that
mistakes and poor decision-making regarding health are often a shared experience of the human
condition (i.e., common humanity), may help to lower the probability of health-related selfcriticality and can promote “ownership” of disease, facilitating personal control (Barnard &
Curry, 2011). A sense of connectedness with others could also be predictive of greater
perceptions of control, if individuals feel as though others can provide them with resources (e.g.,
health-related information) or assistance during the treatment process (e.g., transportation,
emotional support; Wells, Gulbas, Sanders-Thompson, Shon, & Kreuter, 2014).
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Overall, our review of the literature suggests that the ability to engage in self-compassion
may be predictive of a greater perceived sense of internal control - by promoting the
development of a common humanity perspective of illness, increasing attentiveness to the
present moment and controllable elements of the illness experience, and by encouraging
individuals to be kind to the self in the face of illness (Barnard & Curry, 2011; Neff et al., 2007;
Reyes, 2012). Such perceptions of control and personal responsibility for health, including
engagement in proactive health-related behaviors, appear to be important for maintaining
acceptable quality of life during illness, and even for remission of disease (Beckjord et al., 2009;
Kidd et al., 2009; Laffrey & Isenberg, 2003). One factor often affected by perceptions of control
that is directly associated with HRQL and which, thus, may be positively influenced by selfcompassion, is treatment adherence, a patient-centered factor that is crucial for improvements in
health and HRQL.
Treatment Adherence
One of the most controllable, and potentially malleable, aspects of health promotion and
the illness experience, is adherence to the recommendations of healthcare providers; yet, rates of
non-adherence and its negative health consequences are high (Bender et al., 2014; Patridge,
Avorn, Wang, & Winer, 2002; Puts et al., 2014). The World Health Organization (WHO) defines
treatment adherence as “the extent to which a person’s behaviour – taking medication, following
a diet, and/or executing lifestyle changes, corresponds with agreed recommendations from a
health care provider” (WHO, 2003, p. 3).
Among chronically ill persons living in developed countries, the average rate of treatment
adherence is 50%, and nonadherence rates vary relative to the type of condition or treatment
(WHO, 2003); for instance, a 50% - 70% nonadherence rate has been identified for longer-term
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conditions or those requiring significant lifestyle changes (e.g., diabetes; Dimatteo, Hays, &
Sherbourne,1992; Martin, Williams, Haskard, & DiMatteo, 2005). Such high rates of
nonadherence may be due to the complexity of the regimen itself, or the time and effort required
to fully comply with a provider’s recommendations. Among individuals taking more than 13
pills daily, adherence rates may be as low as 20%, as it is difficult to keep track of dosages and
scheduling (Martin et al., 2005). Furthermore, the inconvenience of general lifestyle changes,
and time required to engage in health promotion activities, may be a deterrent to adherence
(DiMatteo et al., 1992).
Such barriers to adherence, especially for lifestyle modifications, have important
implications for the cancer population, given the potential burden imposed by many guidelines
put forth by the WHO: 1.) Accumulate a minimum of 150 minutes of moderate-to-strenuous
exercise or 60 minutes of strenuous exercise per week; 2.) Consume at least five servings of
fruits and vegetables each day; and, 3.) Avoid smoking (WHO, 2003). For a variety of reasons
(e.g., time, effort, motivation), rates of nonadherence to these guidelines, for cancer patients, are
estimated to be 70% (exercise), 48% - 74% (diet), and 20% - 24% (smoking; Blanchard,
Courneya, & Stein, 2008). Findings from other cancer-focused studies indicate that 60% of
cancer patients do not take pain medications as prescribed, 23% do not keep appointments for
chemotherapy, and 16% - 33% withdraw from the recommended treatment (Denois et al., 2011;
Spiegel, 1997). Taken together, these findings indicate treatment nonadherence is a significant
public health concern, at both the preventive and interventive levels.
Treatment Adherence and Physical HRQL
What is more concerning, perhaps, are the high rates of medical consequences, including
mortality, that occur because of nonadherence; for instance, in the U.S., an estimated 125,000
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treatment adherence-related deaths occur each year (Martin et al., 2005). In general, a failure to
comply with treatment recommendations increases risk for the development of other chronic
health conditions (e.g., diabetes, high cholesterol), reduces disease-free time, and increases risk
for premature mortality (Bender et al., 2014; Martin et al., 2005; Patridge et al., 2002; Puts et al.,
2014; WHO, 2003). Additionally, treatment nonadherence is associated with an increased
number of physician visits and hospitalizations, and a greater number of days spent in the
hospital upon initial admission or readmission (Bender et al., 2014; Patridge et al., 2002).
Finally, it is noteworthy that treatment nonadherence may lead to the mistaken assumption of a
patient’s deteriorating clinical condition, and physicians may advocate for dose reductions or
cessation of therapy, ultimately causing more harm, than good, to physical health and life
expectancy (Bender et al., 2014; Patridge et al., 2002).
Above and beyond the association between treatment adherence and objective measures
of health, individuals who engage in higher rates of treatment adherence also report better
HRQL. For example, higher rates of compliance to prescribed medications were associated with
better physical HRQL, fewer disease-related complications, and lower severity of symptoms,
across several samples of Type I and Type II diabetes patients (Broadbent, Donkin, & Stroh,
2011; Perwitasari & Urbayatun, 2016). In a sample of older adults with hypertension (N =
2,180), nonadherence to medication was associated with more perceptions of bodily pain, role
limitations, and worse physical functioning (Holt, Muntner, Joyce, Webber, & Krousel-Wood,
2010), and in a sample of persons living with self-reported knee and/or hip osteoarthritis pain,
HRQL was directly linked to rates of treatment compliance (Conaghan, Serpell, McSkimming,
Junor, & Dickerson, 2016).
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Pertinent to our current study, some previous research has focused specifically on the
adherence-HRQL linkage in the cancer population. Among women diagnosed with breast cancer
(N = 219), compliance to the American Cancer Society treatment recommendations, including
maintaining a healthy diet and weight, and engaging in regular physical activity, was associated
with better HRQL (Song, Hwang, Moon, Noh, & Lee, 2015). In another sample, of women with
metastatic breast cancer (N = 181), there was an overall treatment nonadherence rate of 33%,
with higher rates of noncompliance for hormone therapy (37.9%) and oral chemotherapeutic
agents (36.8%; DiBonaventura, Copher, Basurto, Faria, & Lorenzo, 2014), which in turn was
predictive of worse functional well-being, as indicated by lower scores on the Functional
Assessment of Cancer Therapy. Finally, in a large-scale study of women with a variety of cancer
diagnoses (N = 2,193), there were significant differences in physical functioning and role
limitations, relative to rates of adherence for lifestyle recommendations pertaining to diet,
exercise, and body mass index (Inoue-Choi, Lazovich, Prizment, & Robien, 2013), with the
authors positing that regular physical activity or dietary balance may have led to better
cardiopulmonary functioning, greater muscle strength, and a lowering of body mass index and, in
turn, to perceptions of better physical health.
In sum, treatment adherence appears to have implications for HRQL among persons with
a chronic illness; yet, rates of nonadherence remain high for many persons living with chronic
conditions, including cancer. Numerous factors, both external and internal in nature, are believed
to influence rates of adherence in the context of chronic illness, and the degree to which such
factors can be changed to promote better adherence and HRQL varies considerably.
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Factors Influencing Treatment Adherence
Treatment adherence may be influenced by social structural factors, which are external
in nature, meaning they are primarily outside of one’s locus of control and, thus, largely
unchangeable. For instance, clinic convenience (e.g., location, hours, scheduling), waiting times,
and length of doctors’ appointments are significant predictors of treatment adherence (Denois et
al., 2011; Patridge et al., 2002; Puts et al., 2014; WHO, 2003), as are the interpersonal styles of
doctors and patient trust in healthcare providers (Hays et al., 1994; Martin et al., 2005; Patridge
et al., 2002; Paice, Toy, & Shott, 1998; Theofilou & Panagiotaki, 2012). The quality of
interpersonal relationships with friends and family, as well as the availability of social support
(e.g., tangible, emotion-informational, affectionate, positive social interactions), has also been
linked to improved rates of adherence, as well as greater perceived control over illness, enhanced
self-esteem, and a reduction in negative attitudes toward treatment (Magai, Consedine, Neugut,
& Hershman, 2007; Patridge et al., 2002; Sherbourne, Hays, Ordway, DiMatteo, & Kravitz,
1992; Theofilou & Panagiotaki, 2012).
Treatment adherence may also be influenced by condition-related factors, which may
also be quite difficult, or impossible, to change, including the stage of disease, level of disability
or impairment, the presence or absence of symptoms at any given time, and the duration or
perceived severity of those symptoms (Bender et al., 2014; Patridge et al., 2002; Puts et al.,
2014; Theofilou & Panagiotaki, 2012; WHO, 2003). Treatment characteristics for different
conditions may also influence rates of adherence, with lower rates of adherence for complex
regimens or those which incur immediate or long-term risks (e.g., side effects) that seem to
outweigh the benefits associated with compliance (Bender et al., 2014; Fink, Gurqitz, Rakowski,
Guadagnoli, & Silliman, 2004; Patridge et al., 2002).
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Moving away from the effects of external variables on treatment adherence, many
patient-related factors have also been linked to rates of compliance. In terms of demographic
variables, age differences have been identified, with some research suggesting lower rates of
adherence among older chronically ill persons (Denois et al., 2011; Dimatteo et al., 1992;
Patridge et al., 2002; Theofilou & Panagiotaki, 2012; WHO, 2003), whereas other research
suggests that adherence is most problematic among younger individuals (Atkins & Fallowfield,
2006; Sherbourne et al., 1992). Lower socioeconomic status is also linked to lower adherence,
and furthermore, social class is often associated with race/ethnicity, perhaps explaining the lower
rates of adherence found among minority groups (Bender et al., 2014; Puts et al., 2014;
Theofilou & Panagiotaki, 2012).
Of the aforementioned factors correlated with treatment adherence, most are outside the
scope of personal control and, therefore, cannot be altered to promote higher rates of compliance.
Other contributors to adherence, such as intrapersonal characteristics, are thought to be more
susceptible to change. For example, the intertwined and dynamic nature of psychosocial
variables, including psychopathological and cognitive-emotional (e.g., motivation levels, goalsetting) factors, impacts treatment adherence and HRQL (Brion et al., 2014; Magai et al., 2007;
Martin et al., 2005; Terry et al., 2013; Theofilou & Panagiotaki, 2012), offering many points for
intervention. In terms of psychopathology, mental health problems, including anxiety and
depression, have been shown to negatively impact treatment adherence (Magai et al., 2007;
Theofilou & Panagiotaki, 2012). Hypervigilance may promote engagement in targeted health
behaviors (e.g., lab work, medical appointments), yet the physiological symptoms of anxiety
(e.g., rapidly beating heart) may be exacerbated by treatment for an existing chronic illness (e.g.,
cancer) or increase risk for comorbid health conditions (e.g., heart attack), further complicating
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the treatment regimen as a whole and influencing rates of adherence. Additionally, low energy
levels and motivation characteristic of depression may limit engagement in treatment-related
behaviors, and as well, depression may contribute to negative feelings about one’s life, efficacy
of treatment, and one’s disease.
Beyond psychopathological factors, common cognitive-emotional variables believed to
contribute to lower rates of treatment adherence include fear (e.g., pain of mammogram,
treatment-related side effect), embarrassment related to treatment side effects (e.g., hair loss,
weight gain), or feelings of ineptness or inadequacy related to functional limitations (Magai et
al., 2007). As mentioned in a previous section, perceptions of control over general health or
specific symptoms/illness, are also associated with treatment adherence (Atkins & Fallowfield,
2006). For example, in a sample of female African American persons living with diabetes, low
internal perceived control, coupled with high chance control, was associated with poor rates of
treatment adherence (O’Hea et al., 2005). Yet, it is possible to change an individual’s control
beliefs, which has implications for increasing likelihood of treatment adherence. As one
example, higher perceived internal control, enhanced health-related self-efficacy, and higher
rates of treatment adherence were reported by advanced localized gastrointestinal cancer patients
(N = 61) who completed a training program in relaxation and exercise regimens (Cheville et al.,
2015).
Perceived control is one of the few predictors of treatment adherence that can be altered
at the level of the individual; thus, it is important to identify positive and malleable predictors of
perceived control among persons living with chronic illnesses. Engagement in self-compassion
may be a widely accessible mechanism through which individuals can develop an enhanced
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sense of perceived control and, as a result, be more likely to engage in treatment, with resultant
positive implications for HRQL.
Treatment Adherence, Control Beliefs, and the Role of Self-Compassion
The different elements of self-compassion may be drawn upon to increase the likelihood
that one experiences greater perceptions of internal control, as suggested by previous research.
As an example, the positive associations of common humanity were evident in a qualitative
study of female African American breast cancer survivors who participated in a cancer support
group (Wells et al., 2014). The women reported that participation in the support group enhanced
their perceived sense of control over their illness, and improved rates of proactive health
behaviors and treatment adherence, and these effects were attributed to the emotional (e.g.,
listening ear) and instrumental (e.g., health information, transportation) support provided by
group members, ultimately making them feel as though they were not alone in their suffering.
In addition to the positive effects of actual and symbolic connectedness with others (i.e.,
common humanity), mindfulness may also be predictive of greater control and treatment
adherence. For instance, mindfulness activities (e.g., deep breathing, guided muscle relaxation)
emphasize self-regulation and control over different body parts or physiological processes which,
in turn, contribute to the restoration of emotional balance and generalize to greater feelings of
control over the present moment or, more broadly, the illness experience (Germer & Neff, 2013).
As an example, in a study of individuals living with heart disease and diabetes, mindfulnessbased activities were associated with improvements in selective and executive functioning,
decreasing the probability of medication nonadherence (Salmoirago-Blotcher & Carey, 2017).
Other mindfulness activities, such as weekly participation in full body scans (i.e., purposeful
attention to sensations in different body parts), may be used to further iterate the benefits of
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treatment adherence and control over health, as such activities may draw attention to
improvements in physiological sensations (e.g., pain) over the course of time, and individuals
may attribute such changes to participation in treatment regimens (Hardison & Roll, 2016).
Finally, existing research highlights the importance of self-kindness, as it relates to
perceived control and health behaviors. For example, in a sample of persons living with head or
neck cancer (N = 55), a high level of self-blame and low perceived control was associated with
greater likelihood of continued smoking behaviors in the future (Christensen et al., 1999),
whereas those with greater control were less likely to report fear of cancer recurrence. In this
case, self-kindness may help one to move on from health-related infractions, allowing
individuals to accept an appropriate amount of responsibility for their past health actions, thereby
increasing likelihood of a perceived sense of control over their present and future health (Reyes,
2012). Furthermore, extending gentleness and patience toward the self as one partakes in new
lifestyle changes (e.g., smoking cessation), may be important for decreasing risk of negative
feelings (e.g., frustration), perceived inadequacy, or a loss of control related to personal actions
(e.g., chain smoking; Neff, 2003). This ability to direct kindness toward the self, in conjunction
with the development of a sense of common humanity and participation in mindfulness-based
activities, may be associated with health promotion in the context of chronic illness, by
increasing the probability of internal control beliefs, encouraging treatment adherence, and
enhancing HRQL.
Statement of the Problem
Although the existing literature describes basic associations between the variables of
interest in our study, no previous research has examined the interrelations between selfcompassion, control beliefs, treatment adherence, and physical HRQL, in a single model, nor in a
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sample of individuals with cancer. Given the oft-perceived uncontrollability of cancer, and the
recognized health benefits of treatment adherence, it is clinically important to better understand
cognitive-emotional and psychosocial characteristics, such as self-compassion and perceptions of
personal control, that might contribute to HRQL, and which are therapeutically malleable. As
such, in the current study, we examined the association between self-compassion and HRQL, and
the potential serial mediating effects of control beliefs and treatment adherence, in a national
sample of individuals with cancer.
Hypotheses
1. At the bivariate level, we hypothesized that (a) self-compassion would be positively
related to treatment adherence, physical HRQL, and the general control, symptom
control, and mastery/health self-efficacy subscales of the CBI, and negatively related to
the chance control subscale; (b) general control, symptom control, and mastery/health
self-efficacy would be positively related, and chance control would be negatively related,
to treatment adherence and physical HRQL; (c) treatment adherence and physical HRQL
would be positively related; (d) the CBI subscale of chance control would be negatively
related to subscales of general control, symptom control, and mastery/health self-control;
and (e) all other CBI subscales would be positively related to one another.
2. At the multivariate level, we hypothesized that the linkage between self-compassion and
physical HRQL would be serially mediated by control beliefs (i.e., general, symptom,
chance, mastery/health self-efficacy) and treatment adherence. Higher levels of selfcompassion would be related to higher levels of general control, symptom control, and
mastery/health self-efficacy, as well as lower levels of chance control and, in turn, to
greater rates of treatment adherence and better physical HRQL.
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CHAPTER 2
METHODS
Participants and Procedures
In our Institutional Review Board approved study, data was collected from 235
individuals living in the United States who self-reported being in remission from cancer or
currently living with cancer. Participants were recruited through cancer-related state and
national-level organizations, support groups, blogs, and social media websites. Using a secure
server via Survey Monkey, all participants provided electronic informed consent prior to
completion of online self-report measures. Participants did not receive compensation for their
participation.
In our study, not all respondents answered every item in the demographics section.
resulting in different sample sizes across demographic variables. Our sample was predominantly
female (64.4%; n = 152), with 35.2% identifying as male (n = 83). The majority of participants
identified as White (91.5%; n = 216), 2.1% as Hispanic or Latino/a (n = 5), 1.7% as Black or
African American (n = 4), 1.7% as Multiracial (n = 4), .8% as American Indian or Alaska Native
(n = 2), and .4% as Asian or Asian Indian (n = 1). Most participants were married (71.6%; n =
169), 13.1% were divorced (n = 31), 8.1% were single and never married (n = 19), 3.4% were
widowed (n = 8), 1.3% were married according to common law (n = 3), and .4% were legally
separated (n = 1). In terms of employment status, 39% were retired (n = 92), 32.6% were
employed full time (n = 77), 10.6% received disability (n = 25), 8.9% were employed part time
(n = 21), 3% were homemakers (n = 7), 1.7% were unemployed and not seeking paid
employment, .8% were students (n = 2), and .4% were unemployed and seeking paid
employment (n = 1). Nearly all participants reported having health insurance coverage (93.2%; n
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= 220); specifically, 59.3% had private health insurance (n = 140) and 33.5% had public (i.e.,
government supplied) insurance.
Most of our participants reported being in remission from cancer (71.2%; n = 168).
Among all respondents, prostate cancer was the most common current/former diagnosis (26.7%;
n = 63) followed by breast (19.9%; n = 47), colorectal (16.1%; n = 38), skin (6.8%; n = 16),
non-Hodgkin’s lymphoma (4.7%; n = 11), cervical (3%; n = 7), leukemia (2.5%; n = 6), bladder
(2.1%; n = 5), lung (2.1%; n = 5), endometrial (1.7%; n = 4), kidney (1.3%; n = 3), esophagus
(0.8%; n = 2), thyroid (0.8%; n = 2), liver (0.4%; n = 1), and stomach (0.4%; n = 1) cancers. In
terms of disease stage at the time of diagnosis, 21.2% reported stage four cancer (n = 50), 19.5%
stage three cancer (n = 46), 19.1% stage two cancer (n = 45), and 15.7% stage one cancer (n =
37). The most common type of cancer treatment received was surgery (62.3%; n = 147),
followed by chemotherapy (47.9%; n = 113), radiation therapy (41.9%; n = 99),
pharmacotherapy (16.9%; n = 40), targeted therapy (9.7%; n = 23), blood product donation and
transfusion (5.9%; n = 14), immunotherapy (4.7%; n = 11), stem cell transplantation (0.8%; n =
2), lasers (0.8%; n = 2), and photodynamic therapy (0.4%; n = 1).
Measures
Self-Compassion Scale – Short Form (SCS-SF)
Self-compassion was assessed using the Self-Compassion Scale – Short Form (SCS-SF;
Raes, Pommier, Neff, & Gucht, 2011), a 12-item measure of common humanity (e.g., “I try to
see my failings as part of the human condition”), self-kindness (e.g., “I try to be understanding
and patient toward aspects of my personality I don’t like”), and mindfulness (e.g., “When
something painful happens, I try to take a balanced view of the situation”). Items are rated on a
5-point Likert scale ranging from 1 (“almost never”) to 5 (“almost always”). Total scores range
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from 12 – 60, and after reverse-scoring negatively worded items, an average score is calculated,
with higher scores reflecting greater self-compassion.
The SCS-SF has demonstrated psychometric equivalency to the original 26-item version
of the questionnaire (Raes et al., 2011), with correlations between corresponding subscales and
total scores ranging from r = .84 to r = .97. Internal consistency (Cronbach’s alpha [α]) has also
been demonstrated. In samples of college students, α levels ranged from .67 (mindfulness
subscale) to .93 (total score) on the original version of the scale, and α ranged from .54 (selfkindness subscale) to .87 (over-identification subscale and total score) on the brief version, with
α values somewhat lower on SCS-SF (Raes et al., 2011). Good reliability (α = .89) and criterion
validity (i.e., psychopathological symptoms, shame, Self-Compassion Scale) of the short form
have been demonstrated in both university students and community members (Castilho, PintoGouveia, & Duarate, 2015), as well as clinical samples, including persons with HIV (α = .82,
.71; Brion et al., 2014; Rose et al., 2014), diabetes (α = .85; Ferrari, Cin, & Steele, 2017), and
cancer (α = .74; Schellekens et al., 2017).
Control Beliefs Inventory (CBI)
The Control Beliefs Inventory (CBI) is a 26-item multidimensional scale designed to
assess health-related control beliefs among adults with and without chronic health problems
(Sirois, 2003a; Sirois, 2003b). The general control subscale assesses the extent to which
individuals believe health is controllable through personal actions (e.g., “If I set my mind to it, I
can improve my health”). The chance control subscale measures the extent to which individuals
believe their health is controlled by random or chance events (e.g., “If I am lucky I will stay
healthy”). The third subscale, symptom control, measures the extent to which individuals feel
ongoing health issues and symptoms can be managed and controlled (e.g., “I can take control of
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my health by managing my day-to-day symptoms”). Finally, the mastery/health self-efficacy
subscale assesses the extent to which individuals feel confident and capable of doing what is
necessary to control their health (e.g., “I am confident that I could deal with any unexpected
health problems”). Items are rated on a 6-point Likert scale ranging from 1 (“strongly disagree”)
to 6 (“strongly agree”). Negatively worded items are reverse-scored. Total subscale scores range
from 5 to 68, and an average score for each dimension is calculated, with higher scores indicative
of greater perceived control.
Psychometric support has been established in community and clinical samples, including
arthritis and inflammatory bowel disease (Sirois, 2003b). Cronbach’s α values for the subscales
ranged from acceptable to excellent across samples: general control (.86 - .91); chance control
(.70 - .78); symptom control (.80 - .89); and, mastery/health self-efficacy (.82 - .86). In a sample
of individuals with tinnitus, internal consistency for the general and symptom control subscales
of the CBI were .84 and .85, respectively (Sirois, Davis, & Morgan, 2006). Criterion validity has
also been established (Sirois, 2003b), with patterns of findings suggesting that CBI subscales do,
indeed, assess the extent of perception that events are under personal control. For instance, the
subscales of general control, symptom control, and mastery/health self-efficacy were
significantly and positively correlated to the internal control subscale of the Multidimensional
Health Locus of Control Scale (MHLC), and the chance control subscale was positively
correlated to the chance subscale of the MHLC. Lastly, the subscales were correlated to other
health-related variables in the expected directions. All subscales were positively related to the
General Perceived Self-Efficacy Scale (i.e., coping efficacy). With the exception of chance
control, all other subscales were positively related to the Brief COPE and Illness Cognitions
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Questionnaire (i.e., adaptive coping) as well as higher ratings for perceived physical (i.e., Brief
Health History Questionnaire) and mental (i.e., Multidimensional Well-being Measure) health.
Medical Outcomes Study General Treatment Adherence Scale (MOSGA)
The Medical Outcomes Study General Treatment Adherence Scale (MOSGA) was
developed for use with individuals living with chronic health conditions, and is a 5-item general
measure of individuals’ tendencies to adhere to medical recommendations from their healthcare
providers (Hays, 1994). Sample items include “I had a hard time doing what the doctor
suggested I do” and “Generally speaking, how often during the past four weeks were you able to
do what the doctor told you?” Participants are asked to reflect upon the truthfulness of each
statement in relation to the self. Items are rated on a 6-point Likert scale ranging from 1 (“none
of the time”) to 6 (“all of the time”). Total scores range from 5 to 30. After reverse-scoring
negatively worded items, an average score is calculated, with higher scores reflecting greater
adherence to treatment.
Internal consistency of the MOSGA has been demonstrated in clinical samples. For
example, among persons living with heart disease, diabetes, and/or hypertension (N = 2,181), the
MOSGA had good internal consistency (α = .81; Hays, 1994). The MOSGA also had good
reliability in a sample of individuals living with hypertension (α = 88; Hamilton, 2003) as well as
cancer patients, including an α level of .80 at baseline and .89 at a six-week follow-up (Jerant,
Franks, Tancredi, Saito, & Kravitz, 2011). Convergent validity has also been established across
several studies. For diabetes patients, higher scores on the MOSGA were significantly associated
with setting and achieving diabetic goals, per a healthcare provider’s recommendations,
including consumption of a low-fat diet, engagement in regular exercise, and taking medication
(Dit, Baban, & Dumitrascu, 2012). Additionally, among persons living with a chronic heart
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condition, the MOSGA was positively correlated to the Left Ventricular Device Patient Home
Management Adherence Scale (r = .40; Casida, Wu, Harden, Chern, & Carie, 2015). Yet another
study showed that for individuals with hypertension, scores on the MOSGA significantly
correlated to other measures of treatment adherence (r = .25 - .34), including pill counts at
routine doctors’ appointments and the Medication Event Monitoring System, which is an
electronic system that tracks the frequency, spacing, and timeliness of opening a pill bottle
(Hamilton, 2003). Furthermore, the MOSGA has demonstrated significant correlations to other
health-related variables. Scores on the MOSGA were positively related to perceived utility of the
treatment and treatment adherence self-efficacy among individuals from an outpatient neurology
clinic (Fuertes, Boylan, & Fontanella, 2009). It was also negatively correlated to disease duration
for individuals with diabetes (Casida et al., 2015). Finally, in cancer patients specifically, higher
treatment adherence was negatively related to pain severity as well as improved physical and
mental HRQL (Jerant et al., 2011).
Short Form Health Survey (SF-12v2)
Physical HRQL, over the past four weeks, was measured using Version 2 of the Short
Form-12 Health Survey (SF-12v2), which is a 12-item measure of perceived health status, with
numerous subscales (Ware, Kosinski, & Keller, 1995). The physical functioning (HRQL-PF)
subscale contains two items which assess the extent to which individuals experience physical
limitations across various life domains (e.g., “moderate activities, such as moving a table,
pushing a vacuum cleaner, bowling, or playing golf”), and participants respond on a 3-point
Likert scale ranging from 1 (“yes, limited a lot”) to 3 (“no, not limited at all”). Relatedly,
perceived role limitations due to physical functioning (HRQL-RP) is a two-item subscale
designed to estimate the extent to which individuals experience difficulties in the completion of
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work-related activities due to illness-related symptoms or constraints (e.g., “were limited in the
kind of work or other activities”). Participants respond on a 5-point Likert scale ranging from 1
(“all of the time”) to 5 (“none of the time”). Given our focus on physical HRQL among
individuals living with a past or present history of cancer, we focused exclusively on
participants’ responses for these two subscales.
However, the SF-12v2 contains additional related constructs, including bodily pain
(HRQL-BP), which is a single item measure of the extent to which pain interferes with the
completion of daily work activities. General health (HRQL-GH; 1 item) measures an
individual’s perception of their overall health status, whereas vitality (HRQL-VT; 1 item)
assesses energy levels. Social functioning (HRQL-SF; 1 item) estimates the degree to which
health problems interfere with an individual’s ability to participate in social interactions or
recreational activities. Role limitations due to emotional health (HRQL-EH), comprised of 2
items, assesses perceived limitations in the completion of activities due to emotional health
problems. Finally, the mental health subscale (HRQL-MH; 2 items) measures fluctuations in
mood (e.g., “felt downhearted and blue”). Score ranges vary, and higher scores are indicative of
better HRQL in that domain.
In addition to the other subscales and single-item measures, the SF-12v2 also yields two
composite scores: Physical Components Summary (HRQL-PCS) and Mental Components
Summary (HRQL-MCS). Both composite scores are comprised of all items, with differential
weight assigned to each single-item measure or subscale. HRQL-PCS assigns greater weight in
scoring to physically-oriented items, including HRQL-PF, HRQL-RP, and HRQL-BP. For the
HRQL-MCS, more weight is assigned to psychologically-oriented items including HRQL-VT,
HRQL-SF, HRQL-EH, and HRQL-MH.
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The SF-12v2 has demonstrated equivalency to a longer version of the questionnaire (SF36v2). For example, in a sample of persons living with cervical or lumbosacral spinal disorders,
correlations ranged from .88 - .95 for PCS and the correlation was .97 for MCS across subgroups
of patients (Lee, Browell, & Jones, 2008). The single item measures and subscales were also
correlated to one another across the long and brief versions of the questionnaire, ranging from
.69 (HRQL-GH) to .99 (HRQL-EH). Construct validity of the SF-12v2 has also been
demonstrated in clinical samples. For example, among renal transplant recipients, PCS was
significantly related to the physical (r = .43) and fatigue (r = .42) subscales of the Kidney
Transplant Questionnaire, and MCS was positively correlated to the emotional (r = .26) and
fatigue subscales (r = .48; Chisholm-Burns, Erickson, Spivey, Gruessner, & Kaplan, 2011). In
another study of individuals with chronic illness, the SF-12v2 was positively related to the EQ5D, which is a five-dimensional European HRQL measure for the domains of mobility, self-care,
engagement in usual activities, pain / discomfort, anxiety/depression, and general health.
Correlations of these dimensions to PCS ranged from .24 (anxiety/depression) to .61 (pain), and
correlations for MCS ranged from .21 (self-care) to .61 (anxiety/depression; Cheak-Zamora,
Wyrwich, & McBride, 2009). Finally, in a cancer study, scores on the Bowel Function Index
measure were significantly related to several SF-12v2 single-item measures and subscales
including HRQL-PF (r = .21), HRQL-BP (r = .32), HRQL-SF (r = .38), HRQL-EH (r = .41), and
HRQL-MH (r = .39; Wendel et al., 2014).
In addition to being valid, the SF-12v2 also appears to be a reliable measure of HRQL.
Among individuals who received a renal transplant, internal consistency for the summary scores
ranged from good (MCS α = .88) to excellent (PCS α= .92; Chisholm-Burns et al., 2011). Good
internal consistency was also demonstrated in a sample of heart disease patients, with α values of
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.87 (PCS) and .84 (MCS; De Smedt et al., 2012). Finally, internal consistency of the SF-12v2 has
been demonstrated in the cancer population. In a sample of rectal cancer survivors, internal
consistency of the SF-12v2 subscales varied, with α values of .77 (HRQL-PF), .86 (HRQL-RP),
.75 (HRQL-EH), and .71 (HRQL-MH; Wendel et al., 2014). As well, reliability of the composite
scores has been demonstrated in the cancer population, with α levels of .89 and .73 for PCS and
MCS respectively (Bhandari & Payakachat, 2016).
Statistical Analyses
Covariates
Given the existence of well-established health disparities, and the influence of
demographic and psychosocial variables on health behaviors and quality of life, numerous
covariates were proposed for our analyses. For instance, in terms of demographic variables,
biological sex is related to differences in levels of self-compassion, adherence to treatment
recommendations, and health (Magai et al., 2007; Neff, 2003; Siegel et al., 2012), and age
disparities have been identified for rates of treatment adherence and self-reported physical
HRQL (Patridge et al., 2002; Reeve et al., 2012). Racial and ethnic differences also had to be
accounted for given literature showing differences in terms of health-related beliefs of control,
treatment adherence and HRQL (CDC, 2016b; O’Hea et al., 2005; WHO, 2003). As such, we
covaried age, race/ethnicity and sex in all analyses.
Further, we accounted for the potential effects of disease characteristics and health-care
related factors. As an example, cancer status (i.e., current diagnosis versus remission) or stage of
disease (i.e., Stage 1, 2, 3, 4) may influence the extent to which individuals can engage in selfcompassion, perceive control over their disease, or follow treatment recommendations (Bender et
al., 2014; Przezdziecki et al.,2013; Ranchor et al., 2010). The availability and affordability of
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different types of insurance (e.g., Medicaid, private) may influence perceived control and one’s
ability to engage in treatment, such as expensive medications or surgical procedures (Theofilou
& Panagiotaki, 2012; Wallston, 2001). Because of these associations, we also covaried cancer
status, cancer stage and insurance coverage, in all planned analyses.
All covariates that were non-significant across all models were removed from further
analyses, in accordance with the principle of parsimony (McCullagh & Nelder, 1989). According
to this principle, preference should be given to models containing the fewest possible
assumptions and variables that also yields the best possible predictive or explanatory value.
Simpler models also have greater generalizability in the social sciences. After nonsignificant
covariates were removed, all hypothesized multivariate models were reanalyzed.
Bivariate Analyses
All analyses were conducted using the Statistical Package for the Social Sciences (SPSS),
Version 24. We used Pearson’s product-moment correlations to examine the associations
between, and independence of, self-compassion, control beliefs, treatment adherence, and
physical HRQL. A multicollinearity cutoff of r > .80 was used, which is a level that has been
proposed in the social sciences to minimize risk of biased parameter estimates (Abu-Bader,
2011). Bivariate correlations were examined in the total sample and in subgroups of participants
categorized by disease status (i.e., current diagnosis; remitted cancer).
Serial Multivariate Mediation Analyses
Model 6, from PROCESS macro for SPSS, Version 2.16, was used for multivariate
mediation analyses (Hayes, 2013). We examined control beliefs (i.e., general, symptom, chance,
mastery/health self-efficacy) as first order mediators, in separate models, and treatment
adherence as a second order mediator of the relation between self-compassion and physical
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HRQL (i.e., HRQL-PF and HRQL-RP subscales). As well, the proposed models were examined
in the entire sample (i.e., persons with current diagnosis and those in cancer remission), followed
by an examination of how the models worked in subgroups of participants relative to their
disease status (i.e., current diagnosis vs. cancer remission). Preacher and Hayes’ (2008) method
only allows for a single dependent variable per model; therefore, eight independent models were
constructed to examine the linkage of self-compassion, subscales of the CBI, treatment
adherence, and physical HRQL. Thus, we conducted 24 total serial mediations. Sample sizes
varied across models, as not all respondents answered every item on the measures utilized in the
present study.
In serial mediation, several associations can be examined among the variables. A specific
indirect effect is the effect of the DV on the IV through one or both mediators. In our study, the
following specific indirect effects could have been observed: a1b1 = self-compassion related to
physical HRQL through control beliefs; a1a3b2 = self-compassion related to physical HRQL
through control beliefs and treatment adherence; a2b2 = self-compassion related to physical
HRQL through treatment adherence. The total indirect effect is the sum of all specific indirect
effects, denoted as a123 b12 in our study. Additionally, c’ is used to indicate the direct effect of the
IV, which is the effect of the IV on the DV after controlling for all other mediators. In our study,
c’ symbolized the relation between self-compassion and physical HRQL, accounting for the
effects of control beliefs and treatment adherence. Finally, c represents the total effect of the IV
on the DV, and it is calculated by adding c’ and the total indirect effect. In our study, c
represented the linkage of self-compassion and physical HRQL through the mediators of control
beliefs and treatment adherence.
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Serial mediation has several advantages over other methodological approaches in
correlation and multiple regression (Preacher & Hayes, 2008). First, it is possible to determine
the extent to which a specific mediator variable contributes to the relation between an
independent and dependent variable relative to the presence or absence of other mediating
variables in the model. Second, serial mediation reduces the likelihood of parameter bias due to
omitted variables, as it is possible to account for the effects of potential confounding variables by
including them in the model. Third, the PROCESS macro utilizes bootstrapping for serial
mediation analyses, which is a resampling technique that involves taking a sample size of n
cases, with replacement, from the original sample, and this process is repeated 10,000 times, per
the recommendation of Preacher and Hayes (2008). This technique allows for an estimation of
the indirect effect in each resampled data set, and it is used to estimate confidence intervals for
the indirect effect. Additionally, bootstrapping provides an empirical approximation of the
sampling distribution; therefore, this process does not impose an assumption of normality. Other
advantages of bootstrapping include lower Type I error rates and higher power for the study.
Sampling with replacement, especially for studies with smaller sample sizes, increases the
likelihood that the empirical distribution of data will be closer to the actual distribution in the
population. This allows for more accurate estimates, and in turn, the study also has higher power.

54

CHAPTER 3
RESULTS
Descriptive Statistics for Study Variables
Complete descriptive statistics for study variables can be found in Table 1, relative to
cancer status (i.e., current diagnosis vs. remitted cancer). Independent samples t-tests revealed a
statistically significant mean difference for insurance coverage and general control; persons with
a current cancer diagnosis were less likely to have health insurance coverage or perceptions of
general control over health relative to persons in remission from cancer. The two groups were
not significantly different from one another for other study variables.
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Table 1
Descriptive Statistics and T-tests for Study Variables by Cancer Status

Variable

95% CI for
Mean
Difference

Cancer Status
Current Diagnosis

Remitted Cancer

M

SD

n

M

SD

n

Insurance
Coverage

1.12

.47

68

1.06

.36

162

Self-Compassion

3.41

.74

55

3.52

.72

General Control

3.98

1.02

63

4.52

Symptom Control

4.11

.93

62

Mastery/Efficacy

4.23

.85

Chance Control

3.55

Treatment
Adherence
Physical
Functioning
Role Physical

t

df

[-.18, .05]

-1.09*

228

121

[-.13, .34]

.89

174

.83

135

[.27, .81]

3.97*

196

4.57

.79

134

[.21, .72]

3.63

194

62

4.68

.72

136

[.22, .68]

3.91

196

.89

62

3.51

.76

136

[-.28, .20]

-.34

196

4.92

.76

54

4.99

.82

119

[-.19, .33]

.51

171

44.5

13.07

56

47.38

11.04

120

[-.87, 6.62]

1.52

174

24.35

3.93

56

25.96

3.92

121

[.35, 2.86]

2.53

175

Note: A significant mean difference for insurance and general control exists between persons
with a current diagnosis and remitted cancer; those with a current diagnosis are less likely to
have health insurance coverage or perceive general control over their health.
* p < .05
Bivariate Correlations
Total Cancer Sample
Pearson’s product-moment correlational analyses were utilized to test the first hypothesis,
which was largely supported (see Table 2). Self-compassion (SCS) was significantly positively
related to general control (GC; r = .27, p < .01), symptom control (SC; r = .29, p < .01), mastery
/ health self-efficacy, (MHSE; r = .50, p < .01), treatment adherence (TxA; r = .21, p < .01),
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physical functioning (PF; r = .16, p < .05), and role physical (RP; r = .22, p < .01). SCS was
negatively related to chance control (r = -.07), but it did not reach statistical significance.
Additionally, TxA was positively related to GC (r = .22, p < .01), SC (r = .19, p < .05),
and MHSE (r = .45, p < .01). TxA was also positively related to CC (r = .02), though it was a
small and non-significant correlation.
In terms of other correlations for the HRQL variables, there was also a positive relation
between PF and GC (r = .31, p < .01), SC (r = .23, p < .01), MHSE (r = .23, p < .01), TxA (r =
.17, p < .05), and RP (r = .47, p < .01), as well as a negative relation to CC (r = -.10) that did not
reach significance. Additionally, RP was positively (p < .01) related to GC (r = .23), SC (r = .20)
and MHSE (r = .27). RP was correlated to CC (r = -.04) and TxA (r = .13) in the hypothesized
directions, but neither relation was significant.
All control subscales were also related to one another in the expected directions. GC was
positively (p < .01) related to SC (r = .81) and MHSE (r = .56), and negatively related to CC (r =
-.33, p < .01). SC was also positively related to MHSE (r = .54, p < .01) and negatively related to
CC (r = -.26, p < .01). There was also a non-significant, negative relation between MHSE and
CC (r = -.11).
Finally, health insurance coverage, which emerged as the only significant covariate, was
positively (p < .01) associated with SCS (r = .25), GC (r = .24), and SC (r = .17). Health
insurance also had a positive, nonsignificant association to MHSE (r = .09) and RP (r = .02).
There was a negative, nonsignificant association between health insurance coverage and CC (r =
-.06), TxA (r = -.06), and PF (r = -.02).
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Table 2
Means, Standard Deviations, and Bivariate Correlations of Study Variables in Total Cancer Sample
Mean (SD)

SelfCompassion

General
Control

Symptom
Control

Mastery /
Efficacy

Chance
Control

Treatment
Adherence

Physical
Functioning

Role –
Physical

---

.25**

.24**

.17*

.09

-.06

-.06

-.02

.02

SelfCompassion

3.48 (.73)

---

.27**

.29**

.50**

-.07

.21**

.16*

.22**

General
Control

4.35 (.93)

---

---

.81**

.56**

-.33**

.22**

.31**

.23**

Symptom
Control

4.43 (.86)

---

---

---

.54**

-.26**

.19*

.23**

.20**

Mastery /
Efficacy

4.54 (.79)

---

---

---

---

-.11

.45**

.23**

.27**

Chance
Control

3.52 (.80)

---

---

---

---

---

.02

-.10

-.04

Treatment
Adherence

4.97 (.80)

---

---

---

---

---

---

.17*

.13

Physical
Functioning

46.46 (11.7)

---

---

---

---

---

---

---

.47**

Role –
Physical

25.45 (3.99)

---

---

---

---

---

---

---

---

Insurance

Note: SD = Standard Deviation; Self-Compassion = Self-Compassion Scale – Short Form; General Control, Symptom Control,
Mastery/Efficacy, and Chance Control = Control Beliefs Inventory; Treatment Adherence = Medical Outcomes Study General
Treatment Adherence Scale; Physical Functioning and Role – Physical = Short Form Health Survey, Version 2 – Physical Functioning
and Role Physical subscales. * = p < .05; ** = p < .01
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Remitted Cancer
Among persons in remission from cancer, bivariate correlations between study variables
were largely consistent with those in the total sample, in terms of directionality and significance
of associations. Health insurance coverage had a positive association (p < .01) with SCS (r =
.30), GC (r = .31), and SC (r = .25). Additionally, SCS was significantly (ranging from p < .001
to p < .05) and positively related to GC (r = .26), SC (r = .29), MHSE (r = .53), TxA (r = .25),
PF (r = .20) and RP (r = .29). The internal control belief subscale of GC was positively (p < .01)
associated with SC (r = .81), MHSE (r = .49), and PF (r = .32), and it had a negative correlation
to CC (r = -.43, p < .01). SC was positively associated (p < .01) with MHSE (r = .44) and PF (r =
.25), and negatively to CC (r = -.28, p < .01). Additionally, MHSE (p < .01) was positively
related to TxA (r = .41), PF (r = .31), and RP (r = .33). Positive correlations were also observed
between TxA and PF (r = .25, p < .01) and the two physical HRQL measures (r = .45, p < .01).
Contrary to findings in the total cancer sample, neither GC nor SC were significantly
related to TxA or RP, although these correlations remained positive in directionality. Finally, as
compared to our total sample, a negative correlation emerged as significant between CC and PF
(r = -.26, p < .01), in our sample of persons in remission (See Table 3).
Current Cancer Diagnosis
In our sample of persons with cancer, many associations that were significant in our total
sample, became non-significant. Specifically, health insurance coverage no longer had a
significant positive association with SCS, GC, or SC, and SCS no longer had an association with
treatment adherence or our physical HRQL measures. Some of the correlations for control beliefs
also fell out of significance, including the associations between GC and our measures of PF, RP,
and CC, and between the SC subscale and measures of TxA, PF, and RP. Additionally, MHSE
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was no longer significantly related to PF or RP and, similarly, TxA and PF were no longer
correlated.
Some variables, however, did remain significantly associated. SCS continued to have a
positive association to GC (r = .27, p < .05), SC (r = .27, p < .05), and MHSE (r = .44, p < .01).
There was also a positive correlation between GC and our measures of SC (r = .77), MHSE (r =
.57), and TxA (r = .37), and between MHSE and TxA (r = .54, p < .01). Finally, the physical
HRQL subscales (r = .49, p < .01) remained correlated among our respondents with cancer (See
Table 3).
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Table 3
Bivariate Correlations of Study Variables in Subgroups of Participants
Insurance

SelfCompassion

General
Control

Symptom
Control

Mastery /
Efficacy

Chance
Control

Treatment
Adherence

Physical
Functioning

Role –
Physical

Insurance

---

.30**

.31**

.25**

.10

-.03

-.06

-.07

-.05

SelfCompassion

.13

---

.26**

.29**

.53**

.01

.25**

.20*

.29**

General
Control

.12

.27*

---

.81**

.49**

-.43**

.14

.32**

.17

Symptom
Control

.01

.27*

.77**

---

.44**

-.28**

.18

.25**

.17

Mastery /
Efficacy

.04

.44**

.57**

.59**

---

-.09

.41**

.31**

.33**

Chance
Control

-.13

-.21

-.18

-.24

-.11

---

-.02

-.26**

-.06

Treatment
Adherence

-.05

.12

.37**

.20

.54**

.09

---

.25**

.17

Physical
Functioning

.07

.09

.26

.15

.06

.14

-.01

---

.45**

Role –
Physical

.19

.02

.23

.15

.07

-.02

.04

.49**

---

Note: Correlations for persons in cancer remission are listed in the shaded boxes located above the diagonal. Correlations for persons
living with a current cancer diagnosis are listed below the diagonal. SD = Standard Deviation; Self-Compassion = Self-Compassion
Scale – Short Form; General Control, Symptom Control, Mastery/Efficacy, and Chance Control = Control Beliefs Inventory;
Treatment Adherence = Medical Outcomes Study General Treatment Adherence Scale; Physical Functioning and Role – Physical =
Short Form Health Survey, Version 2 – Physical Functioning and Role Physical subscales. * = p < .05; ** = p < .01
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Serial Mediation Results
Proposed serial mediation models were examined in the total sample and in subgroups
according to disease status, including participants with a current diagnosis and those in cancer
remission. Of all covariates proposed for inclusion in the present study, health insurance (i.e.,
“Do you have health insurance?”) was the only covariate which emerged as significant in the
initial analyses. As such, all other covariates were removed from the proposed models. The
analyses were performed again, the results of which are presented below.
Total Cancer Sample
Physical functioning (HRQL-PF). In the general control model, a significant total effect
was observed (c = 3.25, SE = 1.28, p = .01, 95% CI = .72 to 5.78). The direct effect of selfcompassion on HRQL-PF was nonsignificant when mediators (i.e., general control, treatment
adherence) were added to the model (c’ = 1.9, SE = 1.27, p = .14, 95% CI = -.60 to 4.4),
indicating mediation. A specific indirect effect was observed through general control (a1b1 =
1.02, 95% CI = .19 to 2.23). Approximately 4% of the indirect effect variance was accounted for
by our model (R2 = .04, p = .04). In the symptom control model, a significant total effect was
observed (c = 3.21, SE = 1.28, p = .01, 95% CI = .69 to 5.74). The direct effect of selfcompassion on HRQL-PF was nonsignificant when mediators (i.e., symptom control, treatment
adherence) were added to the model (c’ = 1.89, SE = 1.31, p = .15, 95% CI = -.70 to 4.49),
indicating mediation. A specific indirect effect was also observed through symptom control (a1b1
= .81,

95% CI = .14 to 1.95). Approximately 4% of the indirect effect variance was accounted for

by our model (R2 = .04, p = .04). In the mastery / health-related self-efficacy model, a significant
total effect was observed (c = 3.14, SE = 1.25, p = .01, 95% CI = .67 to 5.6). The direct effect of
self-compassion on HRQL-PF was nonsignificant when mediators (i.e., mastery / health-related
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self-efficacy, treatment adherence) were added to the model (c’ = 1.65, SE = 1.41, p = .24, 95%
CI = -1.13 to 4.44), indicating mediation. No specific indirect effects were observed.
Approximately 4% of the indirect effect variance was accounted for by our model (R2 = .04, p =
.04). In the chance control model, a significant total effect was observed (c = 3.03, SE = 1.26, p =
.02, 95% CI = .54 to 5.53). The direct effect of self-compassion on HRQL-PF was nonsignificant
when mediators (i.e., chance control, treatment adherence) were added to the model (c’ = 2.38,
SE = 1.29, p = .07, 95% CI = -.16 to 4.93), indicating mediation. Additionally, a specific indirect
pathway was observed through treatment adherence (a2b2 = .59, 95% CI = .02 to 1.69).
Approximately 4% of the indirect effect variance was accounted for by our model (R2 = .04, p =
.06). See Table 4 and Figure 1.
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Table 4
Total Cancer Sample – Specific Indirect Effects between Self-Compassion and Physical
Functioning for Serial Mediation Utilizing Control Beliefs and Treatment Adherence
95% CI
Effect

b

Lower

Upper

General Control

ab
a1b1
a1a3b2
a2b2
R2

1.35
1.02
.05
.28
.04*

.31
.19
-.01
-.14

2.81
2.23
.31
1.17

Symptom Control

ab
a1b1
a1a3b2
a2b2
R2

1.32
.81
.07
.45
.04*

.31
.14
-.01
-.06

2.78
1.95
.34
1.43

Mastery / Efficacy

ab
a1b1
a1a3b2
a2b2
R2

1.48
1.12
.29
.08
.04*

-.00
-.35
-.17
-.13

3.22
2.89
.98
.80

Chance Control

ab
a1b1
a1a3b2
a2b2
R2

.65
.07
-.002
.59
.04

-.03
-.19
-.08
.02

1.84
.68
.02
1.69

Note. a and b represent unstandardized regression coefficients: a1 = direct effect of selfcompassion on control beliefs; a2 = direct effect of self-compassion on treatment adherence; a3 =
direct effect of control beliefs on treatment adherence; b1 = direct effect of control beliefs on
physical functioning; b2 = direct effect of treatment adherence on physical functioning; ab =
Total Indirect Effect; a1b1 = specific indirect effect through control beliefs; a1a3b1 = specific
indirect effect through control beliefs and treatment adherence; a2b2 = specific indirect effect
through treatment adherence. R2 = total indirect effect variance accounted for by the model. CI =
95% confidence interval; 10,000 bootstrap samples; health insurance coverage used as a
covariate.
p < .05
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a3gen = .18*
a3sym = .13
a3mse = .42***
a3cha = .02

Control Beliefs

a1gen = .25*
a1sym = .28**
a1mse = .52***
a1cha = -.04

Self-Compassion

Treatment Adherence

a2gen = .23**
a2sym = .25**
a2mse = .05
a2cha = .27**

b1gen = 4.08***
b1sym = 2.87**
b1mse = 2.17
b1cha = -1.59
c’gen = 1.90
c’sym = 1.89
c’mse = 1.65
c’cha = 2.38

b2gen = 1.23
b2sym = 1.77
b2mse = 1.33
b2cha = 2.16

Physical Functioning

cgen = 3.25*
csym = 3.21*
cmse = 3.14*
ccha = 3.03*

Figure 1. Total cancer sample – serial indirect effects model for physical functioning abilities.
Serial indirect effects model for self-compassion, control beliefs, treatment adherence, and
physical functioning in the total cancer sample. a1b1 = specific indirect effect (self-compassion
related to physical functioning through control beliefs); a1a3b2 = specific indirect effect (selfcompassion related to physical functioning through control beliefs and treatment adherence);
a2b2 = specific indirect effect (self-compassion related to physical functioning through treatment
adherence); a123 b12 = total indirect effect (self-compassion related to physical functioning via
control beliefs and treatment adherence); c = total effect (self-compassion related to physical
functioning); c’ = indirect effect (self-compassion related to physical functioning accounting for
control beliefs and treatment adherence).
* p < .05; ** p < .01; *** p < .001

Role physical (HRQL-RP). In the general control model, a significant total effect was
observed (c = 1.04, SE = .44, p = .02, 95% CI = .18 to 1.91). The direct effect of self-compassion
on HRQL-RP was nonsignificant when mediators (i.e., general control, treatment adherence)
were added to the model (c’ = .70, SE = .45, p = .12, 95% CI = -.18 to 1.59), indicating
mediation. Additionally, a specific indirect pathway was observed through general control (a1b1
= .21, 95% CI = .02 to .57). Approximately 3% of indirect effect variance was accounted for by
our model (R2 = .03, p = .06). In the symptom control model, a significant total effect was
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observed (c = 1.05, SE = .44, p = .02, 95% CI = .18 to 1.91). The direct effect of self-compassion
on HRQL-RP was nonsignificant when mediators (i.e., symptom control, treatment adherence)
were added to the model (c’ = .68, SE = .46, p = .14, 95% CI = -.22 to 1.59), indicating
mediation. A specific indirect pathway was observed through symptom control (a1b1 = .20, 95%
CI = .003 to .54). Approximately 3% of indirect effect variance was accounted for by our model
(R2 = .03, p = .06). In the mastery model, a significant total effect was observed (c = 1.15, SE =
.43, p = .01, 95% CI = .30 to 2). The direct effect of self-compassion on HRQL-RP was
nonsignificant when mediators (i.e., mastery control, treatment adherence) were added to the
model (c’ = .54, SE = .49, p = .27, 95% CI = -.42 to 1.5), indicating mediation. A specific
indirect effect was observed through mastery control (a1b1 = .53, 95% CI = .05 to 1.15).
Approximately 4% of indirect effect variance was accounted for by our model (R2 = .04, p =
.03). Finally, in the chance control model, a significant total effect (c = 1.13, SE = .43, p = .01,
95% CI = .28 to 1.99) was observed and the direct effect reduced in significance when mediators
(i.e., chance control, treatment adherence) were added to the model (c’ = .95, SE = .45, p = .03,
95% CI = .07 to 1.83). No significant specific indirect effects were found. Approximately 4% of
indirect effect variance was accounted for by our model (R2 = .04, p = .03). See Table 5 and
Figure 2.
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Table 5
Total Cancer Sample – Specific Indirect Effects between Self-compassion and Role - Physical for
Serial Mediation Utilizing Control Beliefs and Treatment Adherence
95% CI
Effect

b

Lower

Upper

General Control

ab
a1b1
a1a3b2
a2b2
R2

.34
.21
.02
.10
.04

.06
.02
-.01
-.06

.73
.57
.11
.41

Symptom Control

ab
a1b1
a1a3b2
a2b2
R2

.36
.20
.02
.15
.04

.06
.003
-.003
-.04

.78
.54
.11
.49

Mastery / Efficacy

ab
a1b1
a1a3b2
a2b2
R2

.61
.53
.06
.02
.04*

.17
.05
-.12
-.05

1.14
1.15
.28
.23

Chance Control

ab
a1b1
a1a3b2
a2b2
R2

.18
.01
-.0004
.18
.04*

-.03
-.04
-.03
-.02

.55
.14
.01
.52

Note. a and b represent unstandardized regression coefficients: a1 = direct effect of selfcompassion on control beliefs; a2 = direct effect of self-compassion on treatment adherence; a3 =
direct effect of control beliefs on treatment adherence; b1 = direct effect of control beliefs on role
– physical; b2 = direct effect of treatment adherence on role – physical; ab = Total Indirect
Effect; a1b1 = specific indirect effect through control beliefs; a1a3b1 = specific indirect effect
through control beliefs and treatment adherence; a2b2 = specific indirect effect through treatment
adherence; R2 = total indirect effect variance accounted for by the model. CI = 95% confidence
interval; 10,000 bootstrap samples; health insurance coverage used as a covariate.
* p < .05
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a3gen = .18*
a3sym = .14
a3mse = .43***
a3cha = .02

Control Beliefs

a1gen = .26**
a1sym = .29**
a1mse = .52***
a1cha = -.03

Treatment Adherence

a2gen = .23**
a2sym = .25**
a2mse = .06
a2cha = .28**

Self-Compassion

b1gen = .84*
b1sym = .67
b1mse = 1.01*
b1cha = -.20
c’gen = .70
c’sym = .68
c’mse = .54
c’cha = .95*

b2gen = .45
b2sym = .57
b2mse = .29
b2cha = .64

Role – Physical

cgen = 1.04*
csym = 1.05*
cmse = 1.15**
ccha = 1.13**

Figure 2. Total cancer sample – serial indirect effects model for physical role limitations. Serial
indirect effects model for self-compassion, control beliefs, treatment adherence, and role –
physical in the total cancer sample. a1b1 = specific indirect effect (self-compassion related to role
– physical through control beliefs); a1a3b2 = specific indirect effect (self-compassion related to
role – physical through control beliefs and treatment adherence); a2b2 = specific indirect effect
(self-compassion related to role – physical through treatment adherence); a123 b12 = total indirect
effect (self-compassion related to role – physical via control beliefs and treatment adherence); c
= total effect (self-compassion related to role – physical); c’ = indirect effect (self-compassion
related to role – physical accounting for control beliefs and treatment adherence).
* p < .05; ** p < .01; *** p < .001

Sample of Persons with Active Cancer Diagnosis
Physical functioning (HRQL-PF). Across all proposed serial mediation models, neither
the total effects nor the direct effects were significant. Significant specific indirect effects were
not observed. See Table 6 and Figure 3.
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Table 6
Persons with Active Cancer Diagnosis – Specific Indirect Effects between Self-compassion and
Physical Functioning for Serial Mediation Utilizing Control Beliefs and Treatment Adherence
95% CI
Effect

b

Lower

Upper

General Control

ab
a1b1
a1a3b2
a2b2
R2

.83
.99
-.09
-.07
.01

-1.25
-.61
-1.44
-2.09

3.62
3.86
.18
.48

Symptom Control

ab
a1b1
a1a3b2
a2b2
R2

.56
.57
-.003
-.008
.01

-.93
-.33
-.41
-1.39

3.32
3.34
.26
.94

Mastery / Efficacy

ab
a1b1
a1a3b2
a2b2
R2

.37
.38
-.02
.004
.02

-1.76
-1.80
-1.24
-.72

3.75
3.79
1.13
.86

Chance Control

ab
a1b1
a1a3b2
a2b2
R2

-.30
-.39
-.01
.10
.01

-2.50
-2.60
-.51
-.74

1.18
.31
.07
2.05

Note. a and b represent unstandardized regression coefficients: a1 = direct effect of selfcompassion on control beliefs; a2 = direct effect of self-compassion on treatment adherence; a3 =
direct effect of control beliefs on treatment adherence; b1 = direct effect of control beliefs on
physical functioning; b2 = direct effect of treatment adherence on physical functioning; ab =
Total Indirect Effect; a1b1 = specific indirect effect through control beliefs; a1a3b1 = specific
indirect effect through control beliefs and treatment adherence; a2b2 = specific indirect effect
through treatment adherence; R2 = total indirect effect variance accounted for by the model. CI =
95% confidence interval; 10,000 bootstrap samples; health insurance coverage used as a
covariate.
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a3gen = .27**
a3sym = .15
a3mse = .47***
a3cha = .08

Control Beliefs

a1gen = .26
a1sym = .23
a1mse = .40*
a1cha = -.17

Self-Compassion

Treatment Adherence

a2gen = .06
a2sym = .10
a2mse = -.05
a2cha = .14

b2gen = -1.19
b2sym = -.07
b2mse = -.08
b2cha = .70

b1gen = 3.78
b1sym = 2.47
b1mse = .96
b1cha = 2.22
c’gen = .21
c’sym = .53
c’mse = 1.10
c’cha = 1.42

Physical Functioning

cgen = 1.04
csym = 1.09
cmse = 1.48
ccha = 1.13

Figure 3. Persons with active cancer diagnosis – serial indirect effects model for physical
functioning abilities. Serial indirect effects model for self-compassion, control beliefs, treatment
adherence, and physical functioning in persons with an active cancer diagnosis. a1b1 = specific
indirect effect (self-compassion related to physical functioning through control beliefs); a1a3b2 =
specific indirect effect (self-compassion related to physical functioning through control beliefs
and treatment adherence); a2b2 = specific indirect effect (self-compassion related to physical
functioning through treatment adherence); a123 b12 = total indirect effect (self-compassion related
to physical functioning via control beliefs and treatment adherence); c = total effect (selfcompassion related to physical functioning); c’ = indirect effect (self-compassion related to
physical functioning accounting for control beliefs and treatment adherence).
* p < .05; ** p < .01; *** p < .001.

Role physical (HRQL-RP). Total and direct effects were nonsignificant across models,
and no specific indirect pathways were observed. See Table 7 and Figure 4.

70

Table 7
Persons with Active Cancer Diagnosis – Specific Indirect Effects between Self-compassion and
Role – Physical for Serial Mediation Utilizing Control Beliefs and Treatment Adherence
95% CI
Effect

b

Lower

Upper

General Control

ab
a1b1
a1a3b2
a2b2
R2

.23
.16
.04
.03
.05

-.24
-.14
-.06
-.20

1.00
1.04
.50
.63

Symptom Control

ab
a1b1
a1a3b2
a2b2
R2

.20
.12
.02
.06
.04

-.21
-.14
-.02
-.15

.94
.81
.31
.81

Mastery / Efficacy

ab
a1b1
a1a3b2
a2b2
R2

.13
.03
.14
-.04
.05

-.64
-.79
-.16
-.65

.84
.79
.80
.18

Chance Control

ab
a1b1
a1a3b2
a2b2
R2

.12
-.002
-.01
.13
.04

-.29
-.31
-.32
-.15

1.11
.34
.02
1.05

Note. a and b represent unstandardized regression coefficients: a1 = direct effect of selfcompassion on control beliefs; a2 = direct effect of self-compassion on treatment adherence; a3 =
direct effect of control beliefs on treatment adherence; b1 = direct effect of control beliefs on role
– physical; b2 = direct effect of treatment adherence on role – physical; ab = Total Indirect
Effect; a1b1 = specific indirect effect through control beliefs; a1a3b1 = specific indirect effect
through control beliefs and treatment adherence; a2b2 = specific indirect effect through treatment
adherence; R2 = total indirect effect variance accounted for by the model. CI = 95% confidence
interval; 10,000 bootstrap samples; health insurance coverage used as a covariate.
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a3gen = .27**
a3sym = .15
a3mse = .47***
a3cha = .10

Control Beliefs

a1gen = .27
a1sym = .25
a1mse = .40*
a1cha = -.14

Treatment Adherence

a2gen = .05
a2sym = .09
a2mse = -.06
a2cha = .14

Self-Compassion

b1gen = .61
b1sym = .47
b1mse = .08
b1cha = .01
c’gen = -.54
c’sym = -.49
c’mse = -.37
c’cha = -.39

b2gen = .52
b2sym = .62
b2mse = .74
b2cha = .95

Role – Physical

cgen = -.31
csym = -.29
cmse = -.24
ccha = -.27

Figure 4. Persons with active cancer diagnosis – serial indirect effects model for physical role
limitations. Serial indirect effects model for self-compassion, control beliefs, treatment
adherence, and role – physical in persons with an active cancer diagnosis. a1b1 = specific indirect
effect (self-compassion related to role – physical through control beliefs); a1a3b2 = specific
indirect effect (self-compassion related to role – physical through control beliefs and treatment
adherence); a2b2 = specific indirect effect (self-compassion related to role – physical through
treatment adherence); a123 b12 = total indirect effect (self-compassion related to role – physical
via control beliefs and treatment adherence); c = total effect (self-compassion related to role –
physical); c’ = indirect effect (self-compassion related to role – physical accounting for control
beliefs and treatment adherence).
* p < .05; ** p < .01; *** p < .001

Persons in Remission from Cancer
Physical functioning (HRQL-PF). In the general control model, a significant total effect
was observed (c = 4.4, SE = 1.47, p = .003, 95% CI = 1.49 to 7.3). The direct effect of selfcompassion on HRQL-PF was nonsignificant when mediators (i.e., general control, treatment
adherence) were added to the model (c’ = 2.71, SE = 1.44, p = .06, 95% CI = -.14 to 5.56),
indicating mediation. A specific indirect pathway was observed through general control (a1b1 =
1.06, 95% CI = .07 to 2.61). Approximately 8% of indirect effect variance was accounted for by
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our model (R2 = .08, p = .01). For the symptom control model, a significant total effect was
observed (c = 4.3, SE = 1.46, p = .004, 95% CI = 1.4 to 7.2), and the direct effect of selfcompassion on HRQL-PF was nonsignificant when mediators (i.e., symptom control, treatment
adherence) were added to the model (c’ = 2.6, SE = 1.51, p = .09, 95% CI = -.39 to 5.6),
indicating mediation. A specific indirect effect was observed through symptom control (a1b1 =
.90, 95% CI =.10 to 2.34). Approximately 8% of indirect effect variance was accounted for by
the model (R2 = .08, p = .01). In the mastery control model, a significant total effect was
observed (c = 4.0, SE = 1.44, p = .01, 95% CI = 1.15 to 6.85). The direct effect of selfcompassion on HRQL-PF was nonsignificant when mediators (i.e., mastery control, treatment
adherence) were added to the model (c’ = 1.79, SE = 1.68, p = .29, 95% CI = -1.55 to 5.12),
indicating mediation. There were no significant specific indirect pathways, and approximately
7% of the indirect effect variance was accounted for by the model (R2 = .07, p = .02). For the
chance control model, a significant total effect was observed (c = 3.98, SE = 1.44, p = .01, 95%
CI = 1.13 to 6.83), and the direct effect of self-compassion on HRQL-PF reduced in significance
when mediators (i.e., chance control, treatment adherence) were added to the model (c’ = 3.27,
SE = 1.43, p = .02, 95% CI = .44 to 6.11). No specific indirect effects were identified, and
approximately 7% of the indirect effect variance was accounted for by our model (R2 = .07, p =
.02). See Table 8 and Figure 5.
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Table 8
Persons in Cancer Remission – Specific Indirect Effects between Self-compassion and Physical
Functioning for Serial Mediation Utilizing Control Beliefs and Treatment Adherence
95% CI
Effect

b

Lower

Upper

General Control

ab
a1b1
a1a3b2
a2b2
R2

1.69
1.06
7.05
.59
.08**

.35
.07
-.01
-.10

3.59
2.61
.36
1.96

Symptom Control

ab
a1b1
a1a3b2
a2b2
R2

1.70
.90
.08
.72
.08*

.43
.10
-.02
-.04

3.72
2.34
.50
2.15

Mastery / Efficacy

ab
a1b1
a1a3b2
a2b2
R2

2.22
1.64
.39
.19
.07*

.27
-.24
-.09
-.16

4.37
3.83
1.39
1.31

Chance Control

ab
a1b1
a1a3b2
a2b2
R2

.70
-.05
-.001
.75
.07*

-.58
-1.02
-.09
-.03

2.26
.83
.05
2.16

Note. a and b represent unstandardized regression coefficients: a1 = direct effect of selfcompassion on control beliefs; a2 = direct effect of self-compassion on treatment adherence; a3 =
direct effect of control beliefs on treatment adherence; b1 = direct effect of control beliefs on
physical functioning; b2 = direct effect of treatment adherence on physical functioning; ab =
Total Indirect Effect; a1b1 = specific indirect effect through control beliefs; a1a3b1 = specific
indirect effect through control beliefs and treatment adherence; a2b2 = specific indirect effect
through treatment adherence; R2 = total indirect effect variance accounted for by the model. CI =
95% confidence interval; 10,000 bootstrap samples; health insurance coverage used as a
covariate.
* p < .05; ** p < .01
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a3gen = .12
a3sym = .13
a3mse = .41***
a3cha = -.03

Control Beliefs

a1gen = .21*
a1sym = .27*
a1mse = .55***
a1cha = .01

Self-Compassion

Treatment Adherence

a2gen = .31**
a2sym = .33**
a2mse = .11
a2cha = .34**

b1gen = 4.99***
b1sym = 3.30*
b1mse = 2.97
b1cha = -3.91**
c’gen = 2.71
c’sym = 2.60
c’mse = 1.79
c’cha = 3.27*

b2gen = 1.87
b2sym = 2.22
b2mse = 1.73
b2cha = 2.23

Physical Functioning

cgen = 4.40**
csym = 4.30**
cmse = 4.0**
ccha = 3.98**

Figure 5. Persons in cancer remission – serial indirect effects model for physical functioning
abilities. Serial indirect effects model for self-compassion, control beliefs, treatment adherence,
and physical functioning among persons in remission from cancer. a1b1 = specific indirect effect
(self-compassion related to physical functioning through control beliefs); a1a3b2 = specific
indirect effect (self-compassion related to physical functioning through control beliefs and
treatment adherence); a2b2 = specific indirect effect (self-compassion related to physical
functioning through treatment adherence); a123 b12 = total indirect effect (self-compassion related
to physical functioning via control beliefs and treatment adherence); c = total effect (selfcompassion related to physical functioning); c’ = indirect effect (self-compassion related to
physical functioning accounting for control beliefs and treatment adherence).
* p < .05; ** p < .01; *** p < .001
Role physical (HRQL-RP). For the general control model, a significant total effect was
observed (c = 1.71, SE = .51, p = .001, 95% CI = .69 to 2.73), and the direct effect of selfcompassion on HRQL-RP remained significant when mediators (i.e., general control, treatment
adherence) were added to the model (c’ = 1.4, SE = 2.6, p = .01, 95% CI = .34 to 2.47). No
specific indirect effects were observed, and approximately 10% of the indirect effect variance
was accounted for by the current model (R2 = .10, p = .004). In the symptom control model, the
total effect was significant (c = 1.7, SE = .51, p = .001, 95% CI = .68 to 2.72), and the direct
effect was also significant when mediators (i.e., symptom control, treatment adherence) were
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added (c’ = 1.36, SE = .55, p = .02, 95% CI = .27 to 2.45). No significant specific indirect effects
were observed. Approximately 9% of indirect effect variance was accounted for by our model
(R2 = .09, p = .005). Mediation was observed in the mastery control model; there was a
significant total effect (c = 1.81, SE = .50, p = .001, 95% CI = .81 to 2.8), and the direct effect
fell out of significance when mediators (i.e., mastery control, treatment adherence) were added to
the model (c’ = 1.1, SE = .60, p = .07, 95% CI = -.08 to 2.27). The only significant specific
indirect effect was through mastery control (a1b1 = .67, 95% CI = .03 to 1.64). Approximately
11% of indirect effect variance was accounted for by our model (R2 = .11, p = .002). Lastly, in
the chance control model, a significant total effect was observed (c = 1.8, SE = .50, p = .001,
95% CI = .80 to 2.8). The direct effect of self-compassion on HRQL-RP remained significant
when mediators (i.e., chance control, treatment adherence) were added to the model (c’ = 1.68,
SE = .53, p = .002, 95% CI = .63 to 2.73); thus, no specific indirect pathways were observed.
Approximately 11% of the indirect effect variance was accounted for by the current model (R2 =
.11, p = .002). See Table 9 and Figure 6.
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Table 9
Persons in Cancer Remission – Specific Indirect Effects between Self-compassion and Role –
Physical for Serial Mediation Utilizing Control Beliefs and Treatment Adherence
95% CI
Effect

b

Lower

Upper

General Control

ab
a1b1
a1a3b2
a2b2
R2

.30
.20
.01
.10
.10**

-.08
-.002
-.01
-.22

.83
.63
.10
.50

Symptom Control

ab
a1b1
a1a3b2
a2b2
R2

.34
.19
.02
.14
.09**

-.09
-.03
-.01
-.19

.93
.65
.13
.59

Mastery / Efficacy

ab
a1b1
a1a3b2
a2b2
R2

.71
.67
.03
.01
.11**

.06
.03
-.20
-.11

1.55
1.64
.30
.28

Chance Control

ab
a1b1
a1a3b2
a2b2
R2

.12
-.01
-.0002
.13
.11**

-.23
-.17
-.02
-.20

.54
.10
.01
.53

Note. a and b represent unstandardized regression coefficients: a1 = direct effect of selfcompassion on control beliefs; a2 = direct effect of self-compassion on treatment adherence; a3 =
direct effect of control beliefs on treatment adherence; b1 = direct effect of control beliefs on role
– physical; b2 = direct effect of treatment adherence on role – physical; ab = Total Indirect
Effect; a1b1 = specific indirect effect through control beliefs; a1a3b1 = specific indirect effect
through control beliefs and treatment adherence; a2b2 = specific indirect effect through treatment
adherence; R2 = total indirect effect variance accounted for by the model. CI = 95% confidence
interval; 10,000 bootstrap samples; health insurance coverage used as a covariate.
** p < .01
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a3gen = .12
a3sym = .14
a3mse = .43***
a3cha = -.04

Control Beliefs

a1gen = .22*
a1sym = .28**
a1mse = .56***
a1cha = .02

Self-Compassion

Treatment Adherence

a2gen = .32**
a2sym = .33**
a2mse = .11
a2cha = .35**

b1gen = .89
b1sym = .67
b1mse = 1.21
b1cha = -.35
c’gen = 1.40*
c’sym = 1.36*
c’mse = 1.10
c’cha = 1.68**

b2gen = .31
b2sym = .40
b2mse = .12
b2cha = .36

Role – Physical

cgen = 1.70**
csym = 1.70**
cmse = 1.81***
ccha = 1.80***

Figure 6. Persons in cancer remission – serial indirect effects model for physical role limitations.
Serial indirect effects model for self-compassion, control beliefs, treatment adherence, and role –
physical among persons in remission from cancer. a1b1 = specific indirect effect (selfcompassion related to role – physical through control beliefs); a1a3b2 = specific indirect effect
(self-compassion related to role – physical through control beliefs and treatment adherence); a2b2
= specific indirect effect (self-compassion related to role – physical through treatment
adherence); a123 b12 = total indirect effect (self-compassion related to role – physical via control
beliefs and treatment adherence); c = total effect (self-compassion related to role – physical); c’
= indirect effect (self-compassion related to role – physical accounting for control beliefs and
treatment adherence).
* p < .05; ** p < .01; *** p < .001
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CHAPTER 4
DISCUSSION
Cancer is a global public health concern that adversely impacts health related quality of
life throughout the diagnosis and treatment processes – an effect that often persists even after the
remission of cancer. Yet, certain persons, due to individual-level factors such as self-compassion
and perceptions of control, may be more likely to engage in adaptive health behaviors, such as
treatment adherence, thereby manifesting better physical HRQL. We examined the association
between self-compassion and physical HRQL and the mediating roles of perceived control and
treatment adherence.
In bivariate analyses conducted in our full sample of persons with both current and
remitted cancer, hypotheses were largely supported. Self-compassion was significantly,
positively related to internal perceived control (i.e., general, symptom, mastery/health-related
self-efficacy), treatment adherence, and physical HRQL (i.e., physical functioning, rolephysical), and negatively related to chance control. Additionally, all types of internal control
were positively related to treatment adherence and physical HRQL. Chance control, the only
external control subscale, was significantly, negatively related to general and symptom control.
Additionally, treatment adherence was positively associated with our physical functioning
measure, and both physical HRQL subscales were positively associated.
In exploratory examination of bivariate associations across diagnostic subgroups, some
differential findings in significance emerged, although variables were consistently related in
hypothesized directions. Among persons in cancer remission, general and symptom control were
no longer significantly related to treatment adherence or physical HRQL measures. Among
persons with a current cancer diagnosis, health insurance coverage was no longer significantly
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related to any other study variable. Further, the association between self-compassion and
treatment adherence and physical HRQL fell out of significance; internal control beliefs were no
longer related to chance control or physical HRQL; and, treatment adherence lacked a significant
relation to physical HRQL.
In multivariate analyses, there was mixed support for our hypotheses. In our full sample,
comprised of both persons with an active diagnosis and persons in cancer remission, some
hypotheses were supported. For the association between self-compassion and HRQL related to
physical functioning (HRQL-PF), significant indirect effects were observed through general and
symptom control and, in a model utilizing the chance control subscale, a specific indirect
pathway was observed through treatment adherence. When examining the relation between selfcompassion and role limitations resulting from poor physical health (HRQL-RP), significant
indirect effects were observed for the internal control subscales of general, symptom, and
mastery/efficacy control. Overall, no serial mediation effects were observed in our full sample of
persons with either a current or remitted cancer diagnosis.
We also examined our hypotheses across separate diagnostic categories, those with a
current self-reported diagnosis of cancer, and those in self-reported remission from cancer. In a
set of analyses using only persons reporting a current cancer diagnosis, no specific indirect
effects or serial mediation was observed, contrary to hypotheses. In analyses using persons in
remission from cancer, hypotheses were partially supported. In the relation between selfcompassion and physical functioning, significant specific indirect effects were observed for
general and symptom control, and for the outcome of role limitations due to physical health, the
only significant specific indirect effect was for mastery/efficacy. Again, serial mediation was not
observed.
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Overall, our results suggest that self-compassion has a positive association with physical
HRQL, perhaps due to its influence on perceptions of control over health and illness. Yet, as in
our findings, self-compassion may not always be related to behavioral changes, such as treatment
adherence, or overt improvements in functional and role limitations, warranting critical
exploration of the ability of self-compassion to effect change in the context of symptoms,
impairment and illness. In that regard, we found differential outcome patterns across diagnostic
groups, suggesting that the positive relations between self-compassion, health behaviors, and
physical functioning may be limited.
In the following sections, we discuss our findings in greater detail, including exploration
of bivariate and multivariate results, and consider potential explanations for emergent patterns of
indirect effects and a lack of significant serial mediation effects, as they occur across our canceractive and cancer-remitted groups.
Bivariate Associations of Study Variables
In our total sample of persons living with a current cancer diagnosis or cancer remission,
bivariate hypotheses were largely supported. Our findings contribute to the extant literature in
this area, documenting associations between self-compassion, control beliefs, treatment
adherence, and physical HRQL in the context of chronic illness (Barnard & Curry, 2011;
Gillanders et al., 2015; Neff, 2003).
Total Cancer Sample
In our study, using the total sample, self-compassion was positively correlated to internal
perceived control, treatment adherence, and physical HRQL. To the extent one can acknowledge
the common humanity of illness, engage in mindfulness, and direct kindness toward the self,
they may also experience perceived control over their health, thereby facilitating a higher
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probability of adherence to treatment recommendations and perceptions of positive physical
HRQL (Dimatteo et al., 1992; Cheville et al., 2015; Kidd et al., 2009; Kurtz et al., 2008). To
begin, in previous research, a sense of connectedness, including to others who have battled
cancer, is associated with greater perceived control over illness, and this may be due to the
acquisition of new health information and suggestions for symptom management, thereby
contributing to greater self-efficacy and sense of control over cancer (Adams, Mosher, Winger,
Abonour, & Kroenke, 2018). Across chronic illness samples, including fibromyalgia, arthritis,
and breast cancer, sense of control and empowerment has been linked to active involvement in
treatment (e.g., asking questions, seeking new medications; van Uden-Kraan, Drossaert, Taal,
Sevdel, & van de Laar, 2008) and better ratings of physical HRQL (Beckjord et al., 2009; Kurtz
et al., 2008). Similar patterns were observed in our current study, which utilized a mixed sample
of persons living with a variety of cancer subtypes and disease states, including those with a
current diagnosis or remitted cancer.
Another subcomponent of self-compassion, the practice and process of mindfulness, may
also be related to perceived control and better physical HRQL. For instance, some mindfulness
activities involve training in exertion of physiological control over body systems (e.g., tensing
and relaxation of muscles), with deliberate awareness of and attention to changes in cognitions,
feelings, and sensations (Germer & Neff, 2013; Hardison & Roll, 2016). Such activities may
allow individuals to learn some control over physiological symptoms, and previous studies
indicate a beneficial relation between mindfulness and cancer-related symptoms (e.g., pain) and
subjective ratings of physical health status (Matchin & Armer, 2007). Other mindfulness
exercises encourage non-judgmental awareness of thoughts, feelings, and behaviors (Germer &
Neff, 2013); in the context of cancer, this may help to decrease negative attitudes about
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diagnosis, treatment, or prognosis, as it does during the experience of other chronic illnesses
(Sirois, Molnar, & Hirsch, 2015). Altering cognitive-emotional processing in this manner may
promote a sense of readiness and motivation to combat their diagnosis, rather than becoming
overwhelmed by negative aspects of the illness experience (L’Estrange et al., 2016).
Being kind to the self, through positive self-talk and affirmations (e.g., “I will beat
cancer”; “I am strong enough to complete treatment”), is the final component of selfcompassion, and is associated with greater acceptance of positive and negative aspects of the
illness experience as well as enhanced perceptions of internal control (L’Estrange et al., 2016).
In turn, self-kindness may promote self-caring behaviors (e.g., healthy eating; attending
chemotherapy sessions) and a belief in personal ability to succeed (Barnard & Curry, 2011; Neff,
2003), with beneficial implications for overall health and well-being.
Furthermore, to the extent that one is unable to develop a self-compassionate attitude and,
thus, fail to foster a sense of internal control, the belief that disease prognosis and health
outcomes are determined by luck or random environmental events may arise. This premise is
supported by the negative correlation between self-compassion and chance control beliefs in our
study; that is, less self-compassion is related to stronger belief in fate and less feelings of
personal control. In the absence of a sense of common humanity, individuals may feel alone in
their suffering and may lack the benefits (e.g., emotional and instrumental support) associated
with social connectedness (Wells et al., 2014). With a loss of sense of personal control, persons
with cancer may lose confidence in treatment and recovery, and may choose to leave their health
to fate or chance rather than actively engaging in treatment. Such conciliatory approaches toward
illness and treatment are related to worse perceptions of physical health status and lower
likelihood of successful cancer treatment (Adams et al., 2018).
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Other deficits in self-compassion may also be harmful; for example, in the absence of
common humanity, or the perceived connectedness to others, it may be difficult to engage in
illness-contextual mindfulness. When individuals feel alone in their suffering, they may
experience “tunnel vision,” focusing solely on negative thoughts (e.g., worries of death) and
emotions (e.g., frustration about physical limitations; Barnard & Curry, 2011). This “downward
spiral” of thoughts and emotions can be characterized by a perceived loss of control and
difficulty processing negative emotions and, when such processes occur, adaptive health
behaviors, such as treatment adherence, may be less likely to manifest (Atkins & Fallowfield,
2006; Terry & Leary, 2011), resulting in poorer health (Norton et al., 2005).
In addition to potential difficulties enacting mindfulness throughout the illness
experience, persons with disease may also tend to engage in negative self-talk, such as criticism
for illness-related functional limitations or self-blame for the diagnosis (Barnard & Curry, 2011).
In response to perceived shortcomings and past failures (e.g., “I deserve this diagnosis because I
did not go to the doctor on a regular basis”), self-efficacy may dwindle and patients may adopt a
passive or adversarial approach to coping and treatment, including emergence of a perceived
external locus of control (e.g., fate). Such changes in beliefs may manifest as self-punishment,
for example, with resulting deliberate nonadherence to a provider’s recommendations, and with
negative implications for HRQL and disease outcomes (Atkins & Fallowfield, 2006; Malcarane,
Compas, Epping-Jordan, & Howell, 1995). As with many chronic illnesses, a person may,
indeed, be partially responsible for the development of cancer, due to poor self-care and
maladaptive health behaviors in the past, and this tendency to be neglectful of one’s health is in
sharp opposition to the idea of self-kindness (Norton et al., 2005). Overall, our findings suggest
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that persons who struggle to be self-compassionate during the illness experience, may also be
more likely to hold external control beliefs and experience worse physical HRQL.
Our findings also extend evidence for examining types of perceived control as
independent, yet associated, constructs (De Valck & Vinck, 1996; Wallston, 2001). Subscales
representing an internal locus of control, including general, symptom, and mastery/efficacy
control, were all significantly, positively related, and were all negatively related to chance
control, which represents a form of external perceived control. Such results support a long
history of research in this area and suggest that internal control can be focused on an array of
health-related factors, including specific symptoms, HRQL and ability to successfully engage in
health behaviors (Wallston, 1992), as well as causal attributions for diagnosis, treatment and
related side effects, and perceived risk of cancer recurrence (Link, Robbins, Mancuso, &
Charlson,2004). As such, our study helps to clarify the linkages between internal control, healthrelated cognitions, and health behaviors, particularly because differential findings were observed
across subgroups of cancer patients and survivors.
As well, existing literature indicates greater adaptability and associated health benefits of
internal control relative to external control, as supported by our current findings; that is, chance
control was negatively related to other study variables including internal control, selfcompassion. and physical HRQL. Previously, an internal locus of control has been associated
with illness prevention and management, enhanced physical well-being, adaptation to stressful
life events (e.g., medical diagnoses), and less psychological distress (Kurtz et al., 2008;
Wallston, 1992). On the other hand, external control is related to a greater number of mental
health problems, a helpless attitude toward illness management, disengagement from healthy
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behaviors, and worse physical HRQL (Kidd et al., 2009; Norton et al., 2005; O’Hea et al., 2005;
Ranchor et al., 2010).
Finally, regarding the role of health insurance coverage, patterns of findings were largely
consistent with existing literature. To the extent individuals reported having access to health
insurance, they were more likely to report the presence of individual-level resiliency traits,
including self-compassion and internal control beliefs, as well as higher rates of treatment
adherence and better physical HRQL. In the context of disease, health insurance may foster
perceptions of control, because individuals with insurance have greater access to the resources
necessary to follow through with treatment recommendations (e.g., surgery; medications;
Theofilou & Panagiotaki, 2012; Wallston, 2001). As well, having health insurance is associated
with fewer self-reported chronic health conditions and better HRQL (Lasser, Himmelstein, &
Woolhandler, 2006), consistent with our bivariate correlations. Yet, many potential correlates of
health insurance were nonsignificant in our study and it may be that other related factors,
unexamined in the present study, such as the amount of coverage (e.g., copays; deductibles) or
type of insurance (e.g., public; private), exert a stronger influence on control beliefs, engagement
in health behaviors, or quality of life (MacIntosh & Blades, 2001).
Correlations in Subgroups of Participants
Cancer remission. In our bivariate results for persons with remitted cancer, a noteworthy
change was that general and symptom control were no longer significantly related to treatment
adherence or physical role limitations. For cancer survivors, perceptions of control or a need for
treatment adherence may be less relevant due, in part, to a reduction in severity, or complete
absence, of illness symptoms following achievement of remission, with positive implications for
fulfillment of daily roles and responsibilities. In support of this assertion, among colorectal
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cancer survivors (N = 227), rates of endorsement for illness symptoms (e.g., pain) and functional
difficulties (e.g., walking), as well as perceptions of general HRQL, were comparable to those
obtained in the general population (Ramsey et al., 2002).
In the absence of symptoms or impairments, there may be less requirement or perceived
need to exert control over disease via adherence to treatment-focused regimens. Even if
symptoms persist, they may not be severe enough to significantly alter perceptions of health
status; for instance, among head and neck cancer survivors, scores for general HRQL remained
consistent with population norms, despite reports of continued chronic pain in bodily regions
affected by cancer (Hammerlid & Taft, 2001). Thus, as evidenced by our failure to find
significant associations between perceived internal control and health behaviors and outcomes, in
our remitted sample, it may be that, as symptoms of and distress about active cancer dissipate, so
does the magnitude and impact of internal control. This may also be the result of normal disease
progression. As an example, in a sample of cancer patients assessed one year post-diagnosis,
respondents reported lower scores for internal control beliefs than immediately following
diagnosis (Ranchor et al., 2010), which the authors suggested may be due to limited
opportunities to exert control (e.g., unsuccessful treatment; achievement of remission) and a
simultaneous tendency to focus on non-disease aspects of life, such as the cultivation of social
relationships.
Yet, there may also be an alternative understanding of our lack of findings, recognizing
that not all cancer survivors report a symptom-free life following achievement of cancer
remission. Some individuals may experience late effects of cancer treatment (e.g., urinary or
bowel dysfunction) or unavoidable side effects of maintenance therapy (e.g., nausea) during
cancer remission, as well as the threat of cancer recurrence, which have the potential to erode
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perceptions of control over health and disease (Clark & Talcott, 2006). Furthermore, cancer
survivors often attribute disengagement from household activities (e.g., cleaning) and social roles
(e.g., employment) to the late effects of their cancer and treatment experience (e.g., pain, fatigue;
Crist, 2013), indicating a persistent and broad lack of perceived control over health.
Another consideration is that - even in the context of perceived control and overcoming
one’s cancer diagnosis - it is common for former cancer patients to resume engagement in prediagnosis unhealthy behaviors, such as smoking, alcohol consumption, and lack of a wellbalanced diet (Beesley, Eakin, Janda, & Battistutta, 2008). Survivors may credit themselves for
achieving cancer remission (e.g., full treatment adherence) while failing to recognize the extent
to which their personal health behaviors exert an influence on late effects of cancer and its
treatment, risk for cancer recurrence, or overall health status; that is, as a survivor, perceptions of
control over illness may not manifest uniformly to other areas of health functioning. Lack of a
significant association between control beliefs and physical HRQL may also be due to external
factors that influence subjective ratings of health status, such as the well-established association
between length of survivorship and positive physical HRQL (Ramsey, Berry, Moinpour,
Giedzinski, & Andersen, 2002).
Thus, in the context of cancer remission, where a degree of uncontrollability regarding
potential cancer recurrence often persists, the absence of significant associations between control
beliefs, treatment adherence, and role limitations may require a multi-faceted explanation. For
some individuals, the remission period following cancer may be characterized by relatively few
illness-related symptoms or impairments, requiring less need to implement internal control
beliefs as motivation toward treatment adherence and, perhaps, making perceptions of positive
physical HRQL less dependent on a sense of control. For other cancer survivors, persistence of
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symptoms and late effects of cancer treatment may erode perceptions of control (e.g.,
helplessness), or discourage continued efforts to maintain control (e.g., hopelessness), over
illness and health via engagement in proactive health behaviors (Stein et al., 2008). Furthermore,
individuals in cancer remission may discount the degree to which they can exert control over
potential cancer recurrence (Park & Gaffey, 2007), perhaps leading to engagement in unhealthy
lifestyle behaviors rather than following suggested guidelines for post-cancer health (Burris,
Jacobsen, Loftus, & Andrykowski, 2013; O’Neill et al., 2013; WHO, 2003). Each of these
possibilities may help to explain a weakening of the influence of perceived internal control on
health behavior and health-related quality of life outcomes, for persons with remitted cancer.
Current cancer diagnosis. Similarly, in our bivariate results for persons living with a
current cancer diagnosis, internal perceived control was not significantly associated with
treatment adherence or physical HRQL. This pattern of results has occurred in previous research;
for example, among advanced cancer patients, perceptions of internal control were unrelated to
physical well-being (Brown et al., 2017). It may be that cancer patients, despite belief in their
ability to control health or illness, and regardless of engagement in health behaviors,
concurrently experience poor physical HRQL (Norton et al., 2005), thus weakening the
association between variables. Cancer is unique relative to many other chronic illnesses, in that it
is often viewed as an “uncontrollable disease” and, consequently, perceptions of external control
may be more pervasive in the cancer population, with negative implications for HRQL (Carver et
al., 2000; Ranchor et al., 2010). Yet another possibility is that persons living with cancer have
contradictory beliefs of control; for instance, they may perceive an ability to successfully engage
in treatment while lacking beliefs of control over disease prognosis or death (Volker & Wu,
2011).
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We also found that self-compassion was not significantly associated with treatment
adherence or physical HRQL in our respondents with cancer, highlighting potential limitations of
self-compassion as a resiliency trait. A simple explanation might be that, for persons currently
experiencing cancer symptoms, instances of suffering (e.g., illness symptoms; functional
impairments) are more salient than for those in remission, thus limiting the degree to which selfcompassion can beneficially contribute to engagement in proactive health behaviors or positive
ratings of health (Gillanders et al., 2015). Additionally, even well-meaning engagement in some
of the elements of self-compassion may have unintended negative effects; for example, some
persons with cancer may seek common humanity via participation in online chronic illness
support groups, which can lack oversight by trained medical professionals and, as such, may
result in the receipt of inaccurate medical information or treatment advice that can deleteriously
impact quality of life (White & Dorman, 2001). Finally, as in our subsample of persons in cancer
remission, there are many factors known to influence subjective ratings of health status. For
cancer patients, it may be that stage of disease or type of treatment (e.g., first compared to third
round of chemotherapy) differentially impacts perceptions of health status (Chean, Zang, Lim, &
Zulkefle, 2016) or, perhaps, weakens the beneficial effects of self-compassion.
Despite the numerous nonsignificant correlations in our study, the association between
self-compassion and internal control beliefs remained significant across both of our subgroups
and our total sample. Thus, self-compassion does appear to have a consistently adaptive role in
the context of cancer, given its relation to greater perceptions of internal control over health and
illness, regardless of cancer status.
Taken together, our bivariate hypotheses regarding associations between study variables
were largely supported and consistent with previous research conducted with similar constructs
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and measures. Beyond these basic linkages, multiple regression analyses are needed to provide
greater knowledge of the associations and interactions between constructs. In the following
section, we discuss our serial mediation findings, and the interrelations between self-compassion,
control beliefs, treatment adherence, and physical HRQL, with recognition and consideration of
how these variables function, perhaps differentially, among persons with a past or present cancer
diagnosis.
Serial Mediation Associations in Persons with Current and Remitted Cancer
In serial mediation models, conducted in our full sample of both those living with a
current diagnosis of cancer and those in remission, greater self-compassion was associated with
better physical HRQL. This positive association is consistent with existing research indicating a
linkage between self-compassion, physical symptoms (e.g., headaches) and quality of life, in
both community (Dunne et al., 2016, Terry et al., 2013) and clinical samples (Wren et al., 2012).
We extend these findings, however, by examining these associations across the cancer disease
process (i.e., remitted versus current symptoms), which is marked by perceptions of limited
controllability such as the unpredictability of disease progression, treatment effectiveness, and
recurrence.
As well, perceived control emerged as a possible pathway through which self-compassion
exerts an influence on HRQL; there was a significant specific indirect effect through some types
of perceived internal locus of control, in five of the eight serial mediation models. Broadly, our
finding converges with previous research demonstrating an association between perceived
control over illness and HRQL, including in persons living with Celiac disease (Dowd & Jung,
2017) and a diverse sample of persons living with pulmonary disease, psoriasis, or rheumatoid
arthritis (Scharloo et al., 1998), although it has not been previously investigated as a mechanism
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of action for self-compassion. In the sections below, we discuss these main findings; that is, the
relation between self-compassion and health-related quality of life, and the role of perceived
control in this association.
Self-Compassion and Health-Related Quality of Life
To begin, as noted throughout our manuscript, and as indicated by our findings, there is
robust support for the positive association of self-compassion and physical HRQL, including
within the context of chronic illness. For instance, among obese patients living with
musculoskeletal pain, self-compassion was associated with less pain catastrophizing and
disability, which was attributed to taking a mindful and accepting attitude toward day-to-day
limitations and emotional experiences (e.g., anxiety) related to disability (Wren et al., 2012).
Additional research highlights the importance of mindfulness; for example, among breast cancer
patients, participation in a mindfulness-based stress reduction program was associated with
higher energy levels, feeling “strong,” and perceptions of better physical health (Bisseling,
Schellekens, Jansen, van Laarhoven, Prins, & Speckens, 2017). Similarly, in a sample of breast
and prostate cancer patients, engagement in routine mindfulness meditation was associated with
fewer cardiopulmonary and gastrointestinal symptoms, sleep improvements, and better overall
quality of life (Matchim & Armer, 2007), which the authors suggest may be due to the
ameliorative effect of mindfulness on physiological (e.g., high blood pressure) and psychological
stress (e.g., worry, loss of perceived control). Thus, associations between self-compassion and
health outcomes, including HRQL, are well-supported by existing literature, and we observed
similar patterns in both of our sub-samples, of persons living with active or remitted cancer.
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Effects of Control Beliefs
As suggested by our findings, engagement in self-compassion may be an underlying
motivational factor in the development of a perceived ability to exert control over health and
illness symptoms, with associated health behavior and quality of life changes. In our study,
specific indirect effects were observed through general control, symptom control, and
mastery/efficacy. Although we are the first to investigate the role of control beliefs in the context
of self-compassion, there is a well-established linkage between perceived control and health
outcomes in the literature that must be acknowledged, including among those with cancer. For
instance, in ovarian cancer patients (N = 143), lower perceived internal control was associated
with higher impairment, including restrictions in physical functioning and an inability to engage
in usual activities of daily living (Norton et al., 2005). In a sample of breast cancer patients (N =
219), perceived control over illness symptoms was associated with lower scores on the physical
subscale of the Cancer Rehabilitation Evaluation System – Short Form, indicating fewer
difficulties related to activities such as engagement in recreation or employment (Beckjord et al.,
2009). The positive effects of mastery/self-efficacy are also evident in a study of middle-aged
females living with late stage cancer (N = 214); mastery was predictive of lower severity of
fatigue and pain, perhaps due to engagement in proactive health behaviors rather than denial or
behavioral disengagement (Kurtz et al., 2008).
Our findings suggest that, to the extent one can draw upon self-compassion and its
subcomponents, they may experience greater perceived control over illness or health, and better
subjective health status ratings. Further, our results align with and expand upon Julian Rotter’s
social learning theory, which states that cognitive appraisals of situations (e.g., degree of
controllability, self-blame) play a role in behaviors (e.g., treatment adherence), and that

93

experienced outcomes (e.g., better physical functioning, fewer illness symptoms) shape
expectancies about the effectiveness of similar behaviors in the future (De Valack & Vinck,
1996; Scharloo et al., 1998; Wallston, 1992). Self-compassion may be another important factor
to consider within this theory.
Beginning with the component of self-kindness, among persons who receive a cancer
diagnosis, there may also be a tendency to blame the self for past health-related actions (e.g.,
smoking, not going to the doctor) or to self-criticize for current functional limitations (e.g.,
impaired walking) or illness-related changes (e.g., spread of cancer; Terry & Leary, 2011). Selfkindness, as a form of self-soothing, may be associated with positive changes during these times;
for example, the process of growth and change may involve acknowledging past wrongdoings
and accepting an appropriate degree of personal responsibility, rather than being overly selfcritical (Zhang & Chen, 2016).
It is during such times of distress, however, that persons with chronic illness may also
seek to regain control over their health, a change of thought and behavior that can be construed
as an act of self-kindness and which may unfold in the form of lifestyle changes (e.g., smoking
cessation) or compliance to treatment regimens (Terry & Leary, 2011). Indeed, self-compassion
has been linked to an intentional process of taking steps to develop and change as a person (i.e.,
personal growth initiative), which requires possession of relevant skills and knowledge (i.e.,
perceived competence) as well as the ability to overcome setbacks and failures (i.e., resilient
self-appraisals; Barnard & Curry, 2011). In our study, self-compassion appears to have similar
downstream effects, as it is beneficially associated with feelings of mastery and control over
symptoms and health and, in turn, a willingness to engage in proactive health behaviors,
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including adherence to treatment recommendations, consistent with observed patterns in
community-based research studies (Sirois et al., 2015).
For other individuals, self-kindness may serve a different purpose, by helping to assuage
the numerous worries and fears about the future that can emerge during and after the cancer
experience, including the possibility of permanent impairments in functioning, cancer
recurrence, and death (Burman & Weinert, 2007). Positive self-talk (e.g., “I beat cancer, so I can
deal with these side effects too”; “I’m lucky this was detected early”) and self-affirmations (e.g.,
“staying alive for my family is important”) may ameliorate negative thoughts about current or
future health status (Creswell et al., 2007). As well, among those who remind themselves of the
value and importance of good health and staying alive, theory suggests they will also display
stronger intentions and desire to exert control over health and engage in proactive health
behaviors that align with their personal values (Harris & Epton, 2009).
Yet another consideration is the role of self-kindness among persons for whom death is
imminent. Although we did not assess this directly, persons with terminal cancer may hold
regrets about personal behaviors (e.g., lack of accomplishments, poor self-care) or the status of
current relationships (e.g., loss of connection with friends). For these persons, self-kindness may
offset feelings such feelings of shame or guilt, and may motivate attempts to address such issues;
this may also unfold in the form of compliance to a provider’s recommendations to enhance
physical HRQL or longevity of life (Tancredi et al., 2017), so as to increase resources (e.g., time,
energy) to address pertinent end-of-life issues (e.g., reparation of relations, achievement of goals;
Steinhauser et al., 2000). In sum, self-kindness may be related to perceived control and may
influence health perceptions and behaviors, in a variety of ways.
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Mindfulness, the second component of self-compassion, may encourage a reappraisal of
one’s circumstances and health (e.g., “I am fortunate to have limited treatment side effects”) and
a desire to maintain or enhance health and current levels of functioning which, ultimately,
necessitates some degree of control or sense of personal responsibility (L’Estrange et al., 2016;
Neff et al., 2007). As but one example, cancer patients’ participation in mindfulness-based group
therapy was associated with greater acceptance of negative inner experiences (e.g., dysfunctional
attitudes regarding illness; Mehdipour, Rafiepoor, & Alizadeh, 2017) and, as such, may reduce
the impact of negative automatic thoughts, allowing patients to experience greater illness-related
self-efficacy and motivation to overcome current symptoms and functional limitations.
Consistent with this assertion, the positive implications of psychological flexibility were also
demonstrated in a study of prostate cancer patients (Chambers et al., 2016), in which the
mindfulness facets of awareness, non-judgment, and non-reactivity were predictive of better
HRQL, a change due, perhaps, to a shift away from stoicism or rumination about illness and
impairment toward adaptive health-focused perspectives (e.g., “family and friends will help me
overcome this disease”) and behaviors (e.g., exercise regardless of pain).
Furthermore, awareness and acceptance of the inevitability of some illness symptoms and
functional limitations may be associated with adaptive cognitive schemas and beliefs regarding
one’s ability to challenge or overcome a life characterized by suffering (Hamilton, Kitzman, &
Guyotte, 2006). Among cancer patients, for instance, a willingness to live with chronic pain was
associated with lower risk for catastrophic thoughts (e.g., “I cannot do anything for myself
because of the pain”; Gauthier et al., 2009). In another study, of persons with chronic pain, a
common symptom of cancer, participation in mindfulness activities was predictive of greater
self-efficacy for continued and successful activity engagement, regardless of pain severity
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(Turner et al. 2016). Finally, in cancer patients, participation in a meditation and yoga program
was associated with a beneficial shift in illness-related cognitions and attitudes; individuals
reported greater compassion toward the self, more gratitude for life, and stronger beliefs of selfcontrol over illness (Carlson, 2013). Taken together, existing research suggests that mindfulness
may contribute to shifts in perspective about current or future illness experiences, including
perceptions of control, with implications for health behaviors and quality of life.
Common humanity, the third element of self-compassion, involves development of a
sense of connectedness with others (e.g., to others with or who have survived cancer) and may be
especially important given that loneliness is a common presenting concern among persons living
with cancer; they report feeling “different” from others due to their cancer and often experience
unsupportive or critical interactions with others (Adams, Mosher, Winger, Abonour, & Kroenke,
2018). Specifically, patients report dismissal of their feelings or refusal to talk about the
diagnosis, and a pressure to always be a “cancer hero,” holding back difficult or unpleasant
details of their illness (e.g., treatment side effects; Ussher, Kirsten, Butow, & Sandoval, 2006).
As well, cancer patients who report loneliness are more likely to experience low self-efficacy for
symptom management and a greater number of illness symptoms (Adams et al., 2018).
However, to the extent persons with cancer can find and relate to others with similar life
experiences, they may perceive greater control over their illness and better HRQL. As but one
example, in an online support group for persons living with breast cancer, fibromyalgia, or
arthritis (van Uden-Kraan et al., 2008), group members provided one another with health-related
information, emotional support, and assurance of not being “crazy” regarding illness-related
thoughts and symptoms. In turn, participants reported greater perceived control over their future,
were more accepting of their cancer diagnosis and current symptoms and had an enhanced sense
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of self-efficacy related to treatment (e.g., making decisions, inquiring about alternative options)
and health management (e.g., asking doctor questions, seeking information). Taken together,
existing literature and the current study indicate that one or more of the self-compassion
elements may be pertinent to beliefs of control among persons in the cancer population.
Role of Treatment Adherence
Despite providing evidence for potential pathways of influence from self-compassion to
perceptions of personal control and health, our results also illustrate potential barriers to the
influence of self-compassion; that is, a self-compassionate attitude does not necessarily translate
into a sense of control over illness or symptoms and does not automatically generate motivation
or ability to engage in treatment recommendations. More explicitly, using our full sample, a
specific indirect effect through treatment adherence was observed in only one of eight models
and no serial mediation effects were significant, suggesting that self-compassion may not result
in overt changes to treatment adherence. This could be because there are translational barriers to
the effects of self-compassion, but it is also likely that persons with cancer are already adhering
to treatment to a maximal degree; thus, the effects of self-compassion may be more impactful on
psychosocial than behavioral outcomes, in this context.
Despite a lack of statistically significant serial mediation across models, and the
identification of only one specific indirect effect through treatment adherence (i.e., model
assessing chance control and HRQL-PF), individual linkages between study variables were often
significant, including the association between self-compassion and perceived control and
treatment adherence. Such associations have been previously demonstrated in the disease groups
of diabetes (O’Hea et al., 2005), heart disease, and HIV (Salmoirago-Blotcher & Carey, 2017).
Similar results have been obtained in a qualitative study of cancer patients (Wells et al., 2014);
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connectedness to other persons living with a past or current cancer diagnosis (i.e., common
humanity) was associated with better well-being, including fewer negative reactions to diagnosis
(e.g., self-blame) and treatment, and the acquisition of control-enhancing health advice that
improved perceptions of ability to successfully cope with and overcome illness.
As well, to the extent that individuals in our study reported greater overall adherence to
their provider’s recommendations, they also noted better physical functioning and ability to
complete daily roles and activities, consistent with other cancer-related research (DiBonaventura
et al., 2014; Inoue-Choi et al., 2013; Song et al., 2015). Yet, in our serial models, treatment
adherence was not a linkage in the pathway between self-compassion and HRQL, nor the
pathway between self-compassion, perceived control and HRQL. This lack of findings may
reflect the numerous factors known to deleteriously influence treatment adherence, many of
which were not examined in the present study, such as the time since diagnosis, complexity of
treatment regimens, patient perspectives of treatment (e.g., risk benefit analysis), and
psychopathology (Bender et al., 2014; Patridge et al., 2002).
Another consideration is the differing experiences and expectations of treatment for
persons with a current diagnosis versus those in remission from cancer, with the former group
typically undergoing complex medical procedures (e.g., surgeries) or treatment regimens (e.g.,
chemotherapy) and the latter making behavioral or lifestyle changes (e.g., regular exercise) to
minimize long-lasting treatment effects and risk of recurrence (ACS, 2017; WHO, 2003). As a
result, ability and motivation to adhere to treatment recommendations, as well as selfcompassion and perceived control, may function differently relative to cancer status. To
determine such differences, we examined these same serial models within our sub-sample groups
of persons with active cancer and remitted cancer, which we discuss in the following sections.
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Serial Mediation Associations in Persons with Active Cancer Diagnosis
In our sub-sample of persons with a current cancer diagnosis, our hypotheses were not
supported. Across all models, no significant specific indirect or serial mediation effects were
observed, though a few of the individual pathways between study variables were significant.
Specifically, there was a significant positive association between self-compassion and mastery
(on the a1 pathway), as well as significant positive associations (on the a3 pathway) between
internal control beliefs (i.e., general control; mastery) and treatment adherence. Lack of
significant findings at the multivariate level may be due, in part, to nonsignificant bivariate
associations in this subgroup of participants, but there are likely other factors to consider in the
interpretation of our results. We discuss our pattern of findings in the sections below, to
contribute to an understanding of how, and under what circumstances, individual level
characteristics (e.g., self-compassion, control beliefs) and proactive health behaviors (e.g.,
treatment adherence) are positively associated with physical HRQL in the context of cancer.
Self-Compassion and Health-Related Quality of Life
Contrary to our hypothesis, self-compassion was not significantly associated with selfreported physical HRQL among persons living with a current cancer diagnosis. Our findings may
be understood within the context of self-compassion theory, which suggests that self-compassion
is more salient in times of distress and suffering (e.g., physical or mental), helping to foster
resiliency and protecting against perceived loneliness, overidentification with negative thoughts
and feelings, and self-judgment and criticism (Germer & Neff, 2013; Reyes, 2012). Although it
is unfortunate, some form of suffering must occur before self-compassion is enacted and, at
times, the suffering may outweigh the benefits of self-compassion. In support of this assertion,
among cancer patients in Scotland, greater engagement in each of the self-compassion elements

100

was associated with worse physical HRQL, including greater severity of illness symptoms (e.g.,
nausea) and poorer functional well-being (e.g., employment, recreational activities; Gillanders et
al, 2015).
Another factor to consider is that concerns about disease, illness symptoms and
treatment-related side effects may disrupt any beneficial effects of self-compassion, being,
perhaps, too severe and overwhelming for any form of self-soothing to be effective in promoting
role engagement. For example, it may be difficult to engage in self-kindness in the context of
cancer. Characterological self-blame (i.e., “I got cancer because of who I am”) tends to be
difficult to change because it is an internal, global, and stable attribution, and is also esteembased (Label et al., 2013). As well, behavioral self-blame (e.g., I got cancer because of what I
did”) may be a challenge to overcome, as not all behaviors are modifiable, reversible, or even
controllable (Malcarane, Compas, Epping-Jordan, & Howell, 1995).
More pragmatically, symptoms and side-effects (e.g., pain; fatigue) may hinder one’s
ability to attend in-person cancer support groups (e.g., to be able to benefit from common
humanity) or engage in mindfulness activities that include a physical component (e.g.,
progressive muscle relaxation), perhaps due to pain (Bisseling et al., 2017). Similar translational
difficulties may be experienced for other components of self-compassion; for example,
development of a sense of common humanity may sometimes be counterproductive, perhaps
resulting in lower perceptions of HRQL. In one study, with a Dutch online cancer support group,
some participants reported disempowerment and a loss of perceived control over illness due to
the presence of complaining group members and direct confrontation with negative side effects
of the disease (e.g., death of group members; van Uden-Kraan et al., 2008).
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Such examples suggest that self-compassion, even when present, may not be a panacea,
and that stressors and disease-related experiences, including the often-accompanying emotional
distress, may preclude application or utilization of self-compassion, or may dampen or negate its
beneficial effects. As our findings highlight, these types of implementation barriers may have
downstream effects on cognitive-behavioral functioning, including perceptions of control and
treatment adherence, and, ultimately, health-related quality of life.
Effects of Control Beliefs
Additionally, no specific indirect effects were observed for the association of selfcompassion and physical HRQL through control beliefs, in contrast to previous research and our
hypotheses. For persons with cancer, this may suggest that a perceived sense of internal control
over health is not a necessary or sufficient condition for positive perceptions of health. However,
the benefits of internal control for health in persons with cancer has been previously documented
and, in our current study, is reflected by significant associations (a3 pathway) for the relations
between subtypes of control beliefs (i.e., general control; mastery) and treatment adherence. For
example, in colorectal cancer patients, an internal locus of control has been linked to physical
HRQL via assumption of an active role in the management of treatment-related side effects, such
as re-dressing surgical wounds, and making judgments about the need to use pain medications
(Kidd et al., 2009).
Despite the observed effects of perceived control on HRQL, limitations may exist in the
degree to which a sense of control translates into significantly better physical HRQL among
those living with current cancer. Some extant literature corresponds with our non-significant
findings; for instance, in a study of advanced cancer patients (N = 100), internal control was not
significantly associated with physical or mental well-being scores on the Functional Assessment
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of Cancer Therapy – General (FACT – G; Brown et al., 2017). Furthermore, one may hold
internal beliefs of control and simultaneously experience poor physical HRQL. In a study of
ovarian cancer patients (N = 143), higher scores on the Cancer Rehabilitation Evaluation System
– Functional Status subscale, indicative of greater perceived impairment, were associated with
low perceived control (Norton et al., 2005); thus, it may be that one’s sense of control or mastery
is eroded by a physical inability to complete tasks or engage in daily activities.
Other previous research has focused on the linkage between external locus of control
(e.g., fate; belief in God) and physical HRQL. In a sample of patients with advanced cancer (N =
20), for instance, persons who reported belief in God as a source of control had, on the one hand,
high rates of adherence to appointments and lab testing, yet reported that current illness
symptoms (e.g., pain) and the timing of their death were outside of their immediate control
(Volker & Wu, 2011). It may be that persons with a current cancer diagnosis receive mixed
messages or have contradictory experiences that weaken the oft-found linkage between control
beliefs and physical HRQL, as in our study. Furthermore, although a greater sense of internal
control, and low levels of chance control, may increase the probability of experiencing better
physical HRQL, there may also be other factors that impact the association between perceptions
of control and health, such as disease (e.g., comorbidities) or treatment characteristics (e.g.,
regimen complexity; Bender et al., 2014; Denois et al., 2011); however, this information was not
available for analysis in our current study. Despite these considerations regarding our lack of
significant findings, perceived control often appears to have some benefit in the context of
chronic illness, yet it is not a sole determinant of physical HRQL in cancer.
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Role of Treatment Adherence
Inconsistent with our hypotheses, across all models, treatment adherence did not emerge
as a significant indirect pathway for the relation between self-compassion and physical HRQL,
nor was there a significant association between treatment adherence and physical HRQL.
Although past research suggests that following medical recommendations and actively engaging
in treatment regimens may increase likelihood of recovery and achievement of cancer remission,
such adherence does not necessarily result in significantly better subjective reports of physical
HRQL at any given moment, given the rigor and discomfort of cancer treatment. In one study,
for instance, women with early-stage breast cancer (N=91) who were engaged in endocrine
therapy, also reported impairments in physical functioning associated with a wide array of
treatment-related symptoms including cognitive difficulties (e.g., forgetfulness), pain, weight
changes, and gynecological symptoms (Bender et al., 2014).
Yet, despite our lack of significant findings, the extant literature largely suggests that
positive health outcomes may be experienced to the extent one can adhere to a provider’s
recommendations (Patterson et al., 2003). For instance, in lung cancer patients, engaging in lowimpact walking and balance exercises was associated with less fatigue, better fatigue
management, and improved mental and physical health-related quality of life, as assessed by the
PCS and MCS of the SF-36 (Hoffman, Brintnall, Given, von Eye, Jones, & Brown, 2017).
In sum, our findings suggest that, among persons with a current cancer diagnosis, selfcompassion is positively associated with physical HRQL, although the exact mechanisms
through which self-compassion translate to better self-rated health remain uncertain, given the
lack of serial mediation and significant specific indirect effects via control beliefs and treatment
adherence. Furthermore, a self-compassionate attitude does not guarantee adherence to treatment
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recommendations or significant changes in perceptions of health status. Yet, our results may not
be representative of all subgroups of cancer patients and may vary relative to the types of
constructs assessed or models proposed; therefore, future research utilizing alternative modeling
and cancer-specific measures, and with persons with homogenous diagnoses (e.g., only one type
of cancer, for instance), is needed to substantiate our findings. Thus, despite these differential
patterns of association, therapeutic promotion of study variables may still have clinical value for
some persons with cancer. In future research, it will be important to assess the potentially
protective effects of our study variables as they manifest during the transition across stages of the
illness experience, as self-compassion, control beliefs and treatment adherence may have
differential psychological value and health benefits at different points in the illness trajectory. In
the current study, we address this possibility, to some extent, by examining our hypotheses in the
context of cancer remission, which we discuss below.
Serial Mediation Associations Among Persons in Cancer Remission
In our subgroup of persons who self-reported being in cancer remission, our hypotheses
were partially supported. Consistent with previous literature, our findings demonstrate a positive
association between self-compassion and physical HRQL, and we extend this relation to persons
living in remission from cancer (Dowd & Jung, 2017; Dunne et al., 2016; Wren et al., 2012). As
well, our results lend support for perceived control as a possible mechanism of action linking
self-compassion and physical HRQL, as there was a significant specific indirect effect through
perceived control (i.e., general, symptoms, mastery/self-efficacy) in three of eight serial
mediation models. No specific indirect effects were observed through treatment adherence, and
no serial mediation effects were found. Our findings suggest, therefore, that for persons in cancer
remission, self-compassion is associated with better physical HRQL due, in part, to its positive
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association with perceived sense of control over health. In the following sections, we examine
this pattern of results and the interrelations between self-compassion, control beliefs, treatment
adherence, and physical HRQL among persons in remission from cancer.
Self-Compassion and Health-Related Quality of Life
Beginning with the basic association of self-compassion and physical HRQL, we found a
significant, positive relation between these variables across all serial mediation models. Cancer
survivors may benefit from drawing upon one or more elements of self-compassion in the
months and years following successful achievement of cancer remission, to provide self-soothing
for what can often be an arduous recovery and healing process; in turn, this ability to be kind to
the self may increase likelihood of better HRQL. Our findings support previous research
suggesting that self-compassion, and its individual components, can be helpful during the postoperative, post-treatment and remission stages of cancer. For example, in a study of female
breast cancer survivors (N = 152), participating in a self-compassion writing exercise was
associated with greater acceptance of, and less negative affect about, treatment-related bodily
changes (e.g., mastectomy, weight changes). This compassion-based writing paradigm also
promoted mindfulness; survivors reported greater likelihood of looking at themselves in the
mirror and accepting their appearance, rather than engaging in harsh personal judgment (e.g., “I
am ugly”), suggesting that self-compassion may help to restore emotional balance in the
aftermath of cancer (Przezdziecki & Sherman, 2016).
Other research has also focused on mindfulness and the extent to which it allows one to
overcome physical symptoms and impairment or adjust to post-treatment bodily changes. For
instance, in a study of the effects of participation in either a mindfulness meditation program
(e.g., body scans, breath awareness, forgiveness meditation) or a mind-body bridging program,
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which involved helping cancer survivors understand how thought patterns (e.g., rumination) are
linked to various bodily states (e.g., muscle tension, fatigue), participants in both groups reported
better sleep quality, and the authors posited that such a change may be predictive of other
markers of HRQL, such as improved physical functioning (Nakamura, Lipschitz, Kuhn, Kinney,
& Donaldson, 2013). Similar effects were found in a study of breast cancer survivors who
participated in either dance/movement therapy or a mindful movement program (Crane-Okada et
al., 2012); participants reported fewer self-judgments or worries about their appearance and
improvements in physical, psychological, social, and spiritual well-being.
Establishing a sense of common humanity may also be important for persons recovering
from chronic illness, including those in cancer remission. For example, in a qualitative study of
persons with a history of breast cancer, participants reported numerous positive aspects of
membership in a survivors’ network (Rosedale, 2009), including connectedness with others
based on shared physical reminders of their cancer diagnosis, such as visible scars, chronic
fatigue, and hot flashes. Group members also expressed satisfaction at not having to maintain a
“heroic survivor narrative,” which is often expected among family and friends, and requires
concealment of ongoing symptoms and fears and a quick return to pre-diagnosis levels of
functioning. To the extent that a cancer survivor can understand the common humanity of their
recovery process, including interacting with others with cancer, and receiving tangible or
emotional support, they may be more likely to experience better HRQL.
Our current results suggest that cancer survivors may benefit from self-compassion, with
translational impact on HRQL. Through engagement in mindfulness-based activities, cancer
survivors may develop a more accepting attitude toward long-lasting illness or treatment-related
symptoms, and through self-kindness may be less self-critical in the face of those changes. As
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well, development of a sense of common humanity, acknowledging the shared experience of
illness, may be valuable in the adjustment process, lessening the perceived impact of disease
after achievement of a cancer-free status. Although self-compassion tends to be most salient in
difficult times, our results lend support for its continued importance and benefits after a pinnacle
point of distress, that being one’s initial cancer diagnosis and the treatment process.
Effects of Control Beliefs
In our subsample of persons in remission from cancer, we examined perceptions of
internal and external control over illness and health as potential mediators of the association
between self-compassion and HRQL. In models containing HRQL-PF as an outcome variable,
specific indirect effects were observed through general and symptom control, and for HRQL-RP,
a specific indirect effect was observed in the mastery model. As discussed in the previous
sections, these linkages can manifest in a variety of ways; however, the process or meaning of
these associations may be somewhat different for those with active compared to remitted cancer.
As we have noted, to the extent that cancer survivors can recognize the common
humanity aspect of their illness experience, they may also believe in their ability to exert control
over their recovery and maintenance of good health functioning. For example, among persons in
a survivors’ network, a sense of connectedness to others allowed participants to openly share
their experiences of symptom burden (e.g., fatigue) and provided social support, during their
attempts to regain control of health and in overcoming social pressures to “get back to normal”
following cancer remission (Rosedale, 2009). These linkages between common humanity,
perceived control and HRQL can be conceptualized within the context of Fredrickson’s broadenand-build model (2004), which suggests that, through both independent and social engagement in
emotionally-rewarding activities, a sense of empowerment and additional positive emotions will
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arise, which can be drawn upon in times of hardship, thus allowing for resiliency, growth, and
longevity (Fredrickson, 2004). Across chronic illness samples (e.g., HIV, cardiovascular
disease), engagement in social activities or emotional disclosure was predictive of higher levels
of humor, gratitude, and optimism, as well as better immune system functioning, less risk for
cardiovascular problems and hospital readmission, and lower mortality rates (Tugade,
Fredrickson, & Barrett, 2004). During the difficult process of survivorship, a sense of common
humanity may help to promote such positive emotionality and, in turn, can strengthen
interpersonal resources, motivation and adaptive skills. As an example, in a study of cancer
survivors’ participation in a Trail to Recovery (CTR) program, which involved group hikes twice
weekly, individuals reported greater likelihood of “choosing to respond for the future” and
perceived capability of taking control of their health (Harmon, 2018), which they attributed to
their connectedness with others in the support group and a normalization of the illness
experience. In this same study, survivors also attributed changes in perspective to their
immersion in natural and transcendent environments; separation from stressors of the “real
world” or “real life” helped to restrict negative thoughts (e.g., “I have no control over my
health”) and encouraged attentiveness to the here-and-now of the hiking experience, somewhat
like mindfulness, although this was not explicitly assessed.
Additional research supports this association between engagement in emotionally
rewarding activities, mindfulness, and perceived control; for example, breast cancer survivors’
participation in an adventure-based activity (e.g., dragon boat racing) was associated with
numerous positive outcomes including establishment of a common bond to other women (i.e.,
common humanity), regaining a sense of control and embracing life, and a tendency to live in the
moment rather than thinking about the past or future (Ray & Jakubec, 2014). Furthermore, the
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process of engaging in mindfulness activities may, itself, be an exertion of control, whether it is a
physiological (e.g., progressive muscle relaxation) or cognitive (e.g., letting go of judgmental
thoughts) action. Upon completion of mindfulness-based exercises, individuals may have
“evidence” of their ability to control some aspects of mind-body functioning, increasing
probability of positive perceptions of health and quality of life (Nakamura et al., 2013). Thus, in
general, our study and previous research suggest that, to the extent cancer survivors are able to
engage in mindfulness, they may also experience enhanced perceptions of control that function
as an inner resource and guide future health behaviors and outcomes.
Finally, in the context of remission from illness, self-kindness may also play a role in the
development and maintenance of an enhanced sense of control. For example, if a cancer
diagnosis is attributable to personal health behaviors (e.g., smoking), an individual may
experience punitive and recriminating feelings toward the self; however, engaging in selfkindness may allow transcendence of these feelings, providing motivation to assert control over
future health-related actions, such as regular exercise or nutritious eating, with positive
implications for HRQL (Neff, 2003; Neff et al., 2007). Consistent with this idea of enhanced
motivation, in a study of five diverse medical samples, including persons with a past or present
cancer diagnosis, dispositional self-compassion was associated with higher rates of treatment
adherence (Sirois & Hirsch, 2018).
Despite evidence for several linkages between self-compassion, control and HRQL, it
must be acknowledged that perceived control did not emerge as a significant specific indirect
pathway across all proposed serial mediation models, suggesting that, as we have previously
noted, self-compassion may not always be associated with higher perceptions of control and
HRQL. This may be due, in part, to the persistence of physiological and psychological symptoms
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even during periods of remission; for example, in a study of prostate cancer survivors (N = 235),
although participants reported their cancer to be “controlled” or resolved, they simultaneously
reported the persistence of urinary, bowel, and sexual dysfunction (Clark & Talcott, 2006). By its
very nature, cancer has some degree of unpredictability and uncontrollability, such that one can
never predict with certainty, nor control, whether cancer will recur, thus increasing perceptions
of vulnerability and decreasing perceptions of physical HRQL among persons in remission
(Barak et al., 2008).
Role of Treatment Adherence
Contrary to our hypotheses, and despite well-established health correlates, selfcompassion was not serially related, via control and treatment adherence, to physical HRQL, and
no specific indirect effects were observed through treatment adherence. Broadly, our lack of
findings may reflect the difficulty of engaging in the process of change and treatment, and the
propensity for individuals to continue to engage in maladaptive health behaviors despite
recommendations from a healthcare provider. Treatment adherence may also be less relevant or
applicable to persons in cancer remission compared to those with an active diagnosis.
Upon achievement of cancer remission, general lifestyle changes and proactive health
behaviors are recommended, including, but not limited to, consumption of a balanced diet,
regular exercise, smoking cessation, minimal alcohol consumption, yearly physicals, and routine
cancer check-ups (WHO, 2003). These recommendations can be thought of as the “treatment”
component of cancer remission; yet, despite such recommendations, existing literature suggests
low rates of positive health behaviors and poor physical HRQL, in persons in remission from
cancer. In a sample of cancer survivors (N = 775), only 15% met the recommendation of five
daily servings of vegetables and 32% - 38% reported regular physical activity, with additional
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concerns about subgroups of participants, including 71% of endometrial cancer survivors being
overweight or obese, and current smoking behaviors reported by 21% of cervical cancer
survivors (Beesley et al., 2008); importantly, those who adhered to the suggested guidelines were
most likely to experience better HRQL.
As well, other factors may interfere with one’s ability to adhere to lifestyle
recommendations, thereby increasing risk for poor HRQL. In a study of cancer survivors (N =
16), assessing a broader range of late effects (e.g., neuropathy, chronic pain, respiratory
problems), an association existed between lingering illness symptoms, physical functioning, and
role limitations, with a particularly noteworthy deterioration in the domain of employment (Crist,
2013). Persistence of symptoms has also been demonstrated among breast cancer survivors, with
symptoms such as pain, fatigue, and loss of upper extremity movement interfering with
employment, participation in recreational activities, and childcare responsibilities (Binkley et al.,
2012).
Despite such results, it is not the case that all persons living with a cancer history, or a
history of illness, always report low rates of adherence or poor physical HRQL. For instance, in a
study of long-term cancer survivors compared to a control group, there were no significant group
differences in rates of engagement in proactive health behaviors (e.g., smoking, physical activity,
diet), suggesting some equivalency of health behaviors between persons in remission from
cancer and the population at large (Bishop et al., 2010). Finally, perceptions of good physical
HRQL have been identified among persons in remission from cancer; for example, in a sample
of colorectal cancer survivors (N = 227), 47% of participants rated their general health as “very
good” or “excellent,” with longer survivorship associated with HRQL ratings consistent with
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persons in the general population without a history of serious medical illness (Ramsey et al.,
2002).
Overall, and taken together, our findings and the existing literature suggest a relation
between intrapersonal processes (e.g., self-compassion, control beliefs), treatment adherence,
and health status among persons in cancer remission. Our study contributes to an enhanced
understanding of the relations between these constructs, and highlights self-compassion as a
potential predictive factor for these and other beneficial health outcomes in persons remitted
from cancer, and as a factor that can be targeted therapeutically.
Clinical Implications
Our findings may have clinical implications. To begin, therapeutically promoting one or
more elements of self-compassion may have positive effects on physical well-being and quality
of life for persons with a past or present cancer diagnosis. Indeed, as we discuss below, within
community-based and chronic illness samples, including persons with cancer, compassion-based
interventions have demonstrated effectiveness in increasing perceived control over health and
higher subjective ratings of health status, as well as greater engagement in proactive health
behaviors.
Given the well-established positive relation between mindfulness and HRQL in clinical
samples, including the cancer population, one suggested intervention is Mindfulness-Based
Stress Reduction (MBSR), which involves participation in a variety of mindfulness activities
(e.g., gentle yoga, walking meditation), psychoeducation about stress symptoms and the mindbody connection, and use of relaxation strategies to modify maladaptive stress responses (Birnie,
Speca, & Carlson, 2010). In a sample of breast cancer survivors, MBSR was associated with
improvements in physical and emotional HRQL (measured by SF-12v2), with maintenance of
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gains at a six-month follow-up (Lengacher et al., 2009). Such approaches are predicated on the
assertion that, by adaptively altering the way one physically or cognitively responds to the illness
experience, subjective perceptions of health may also be improved.
More focused on compassion than mindfulness, and often a component of other
interventions, loving-kindness meditation has also been utilized as a stand-alone technique for
the promotion of self-compassion. This approach involves recalling a feeling of connection to a
loved one, remaining focused on feelings of love and kindness in the present moment, and use of
silent mental phrases (e.g., “may you be healthy and strong”; “may I be happy”) to direct
positive feelings toward the self and other person (Kirby, 2017). Among individuals living with
chronic back pain, engagement in loving-kindness meditation was associated with a reduction in
same-day pain severity and negative affect (e.g., anger; Carson et al., 2005), and such changes in
perceptions of symptoms and HRQL may extend to the cancer population, given the frequency
and severity of pain experienced by many persons during treatment and remission phases of
illness (Adams et al., 2018; Bender et al., 2014).
Other strategies for the promotion of self-compassion tend to integrate traditional
elements of cognitive and behavioral therapies. For instance, in a sample of cancer patients,
Mindfulness-Based Cognitive Therapy (MBCT) was associated with less psychopathology (e.g.,
depression) and stress, and improvements in quality of life, as measured by scores on the FACT–
G, with proposed mechanisms of change being awareness of negative thinking and ability to
disengage from illness-related rumination (Foley, Baillie, Huxter, Price, & Sinclair, 2010).
Another example is Cognitively Based Compassion Training (CBCT), which has several
components, including: non-judgmental awareness of thoughts, bodily states, and environmental
surroundings; developing a realization of how mental states contribute to well-being;
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perspective-taking and realization of the shared human experience of a desire for happiness and
freedom from suffering; and, fostering appreciation and gratitude for social interconnections
(Kirby, 2017). Across samples of breast cancer survivors, CBCT has been associated with
increases in compassion and kindness toward the self and others (Gonzalez-Hernandez et al.,
2018), as well as less cognitive avoidance, enhanced present-moment awareness and processing,
and improvements on the SF-12v2 subscales of vitality/fatigue and physical functioning (Dodds
et al., 2015).
Yet another potential therapeutic direction is Acceptance and Commitment Therapy
(ACT; Luoma, Hayes, Walser, 2017), a derivative of CBT that involves fostering psychological
flexibility, encouraging participation in mindfulness activities, and helping individuals to clarify
their personal values and act accordingly. Through participation in ACT, individuals may
experience gains in self-compassion, develop an adaptive sense of perceived control over health,
and may draw connections between engagement in proactive health behaviors (e.g., treatment
adherence) and personal values (e.g., family). In a theory driven, hypothetical application to a
cancer patient, defusion exercises were used to overcome critical self-talk (e.g., “I am at fault for
this diagnosis because I did not go to the doctor”) that had become a self-fulfilling prophecy, and
mindfulness exercises helped to overcome rumination about past wrongful actions (e.g.,
smoking) and instead focus on the present moment (Angiola & Bowen, 2013). Regarding health
outcomes, previous research demonstrates the benefits of ACT, including less psychosocial
disability among persons in chronic pain (Buhrman et al., 2013) and quality of life improvements
in cancer patients (Feros, Lane, Ciarrochi, & Blackledge, 2013).
Another specific aspect of self-compassion, common humanity, has an important role in
the experience of, and recovery from, chronic illness. More broadly, the availability of support
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systems, including family, friends and others experiencing or recovering from illness, has
numerous benefits. Among breast cancer patients, the size of one’s network and level of
closeness within those relationships was associated with greater perceived instrumental and
emotional support, with positive implications for physical and mental well-being (Bloom,
Stewart, Johnston, Banks, & Fobair, 2001). As well, despite a lack of significant improvements
in quality of life, head and neck cancer patients reported high levels of comfort and satisfaction
associated with having other persons with whom they could discuss illness-related fears and
concerns (Mowry & Wang, 2011); this process of realization may be conceptualized as the
development of a sense of common humanity, and may promote beneficial downstream
cognitive-emotional changes such as greater perceptions of control over health.
Of note, therapeutic interventions to improve perceptions of control over health,
adherence to treatment and HRQL, are also important targets when working with persons with
chronic illness. As one example, greater perceived control over illness symptoms was fostered, in
a sample of breast cancer patients, through a nurse-led intervention that included several
components: a five-minute video of survivors talking about self-care behaviors for the
management of treatment side effects, receipt of a “Self-Care Behaviors” booklet, and five oneon-one in-person counseling sessions within the medical setting (Lev et al., 2001). In another
study, of patients in an oncology clinic, the personal qualities of the physician, including
empathy and attentiveness, were predictive of greater perceived control and self-efficacy
(Zachariae et al., 2003). Thus, by enhancing a provider’s interpersonal communication skills
(e.g., good eye contact, validation) and encouraging a patient-centered focus among oncologists,
beliefs of control may be altered among persons in the cancer population.
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Furthermore, self-efficacy interventions may increase one’s perceived control and
personal ability to engage in proactive health behaviors. Among a community sample with
unhealthy eating habits, participation in a combined self-efficacy and planning intervention was
associated with increased consumption of fruits and vegetables at six-months post-intervention
(Luszczynska, Tryburcy, & Schwarzer, 2007); such beneficial effects may also be applicable to
the cancer population. For example, among cancer patients, deliberate instruction and supervised
participation in physical activities (e.g., group sports, aerobic bicycles) was related to enhanced
self-efficacy for engaging in regular physical activity and to improvements in physical role
limitations, physical functioning, and vitality, as measured by the SF-12v2 (Korstjens et al.,
2008). In another study of cancer patients, participation in a meaning-making intervention,
guided by Albert Bandura’s self-efficacy theory, was associated with significant improvements
in self-esteem and self-efficacy, despite ongoing chemotherapy (Lee, Cohen, Edgar, Laizner, &
Gagnon, 2006). This intervention utilized a narrative, story-telling approach that addressed past
life events and coping strategies, current emotional and cognitive responses to one’s diagnosis,
and life goals, despite the possibility of mortality, and participation was associated with greater
perceived control over the management of illness symptoms and treatment. Finally, in another
nurse-led educational intervention, conducted in hospital oncology wards, participants received
in-person counseling on pharmacological (e.g., medication regimens), non-pharmacological
(e.g., relaxation), and post-discharge (e.g., prescriber of medication) pain management (Jahn et
al., 2014), and reported better pain management than a control group at one-month postdischarge. Thus, our findings, and previous research, suggest that interventions oriented toward
development of self-efficacy may be particularly helpful for enhancing perceived control over
health behaviors, including treatment adherence, and the overall illness experience.
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In fact, additional techniques may be used to directly address treatment adherence among
cancer patients and survivors, and general guidelines have been proposed to inform the
development of adherence-promoting interventions (McNicholl, 2008). For patients, strategies
include: patient education tailored to one’s literacy level; information on dosing, side effects, and
food requirements; involvement of patient, friends, and family members in the treatment process;
and, simplification of the regimen. Clinic-based and health care team strategies to improve
adherence may include: establishment of a trusting relationship with the patient; communication
between clinic visits; timely responses to adverse events or illnesses; medication counseling;
and, continuous monitoring of adherence.
Several interventions guided by these recommendations have demonstrated effectiveness
in the cancer population. In a randomized controlled trial (RCT) of standard chemotherapy
education compared to a tailored intervention group (e.g., chemotherapy education, follow-up
phone calls during treatment; needs assessment), adherence rates were higher for the intervention
group (self-report: 95.1%; pharmacy records: 73.7%) than the control group (self-report: 82.4%;
pharmacy records: 68.8%) at a four-month follow-up (Schneider, Adams, & Gosselin, 2014).
Other research highlights technology as a useful way of increasing treatment adherence.
In one study (Spoelstra et al., 2016), participants were assigned to either a control group (N =
26), which involved written instructions and information about chemotherapy (e.g., side effects,
dosage timing), or an intervention group (N = 49) that involved receipt of text messages (e.g.,
“It’s time to take your [medication]. Doing so is an important step in managing your cancer.
Reply `Taken` when you’ve taken it.”). Across an eight-week timespan, recipients of the
intervention consistently reported fewer and less-severe illness and treatment-related symptoms,
and less interference with daily activities of living. At the study’s conclusion, 86.7% of
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intervention participants reported adherence compared to 79.2% in the control group, lending
support for text messaging as one viable option for increasing rates of compliance among cancer
patients and survivors.
Whether technology-based or delivered as traditional educational/counseling
interventions, existing evidence suggests that it is possible to foster greater self-compassion,
beliefs of control, and treatment adherence among persons with a chronic medical condition.
Although continuing psycho-oncological research is needed, our findings and review of the
literature suggest that cancer patients and survivors can benefit from such interventions, with
salutogenic implications for HRQL. Given the country’s rapid growth in the number of cancer
survivors, as well as the lack of a known cure for cancer, our results and associated clinical
implications may hold value at all stages of the illness experience, beginning with the initial
diagnosis, during treatment, and in the years following achievement of cancer remission.
Limitations and Future Directions for Research
Our study is not without limitations. First, there may be limited generalizability of our
findings due to sample characteristics. Most participants were female and White, and existing
literature suggests there may be differences in the lived experiences of individuals based on sex
and racial or ethnic identity, such as one’s ability to draw upon the self-compassion elements
(e.g., higher self-criticism in females and minority groups) or the influence of religious beliefs
(e.g., fatalism in African American community; ACS, 2016; CDC, 2016b; O’Hea et al., 2005;
Yarnell et al., 2015).
Additionally, our sample was comprised, primarily, of persons in remission from cancer,
rather than persons with a current diagnosis, and our subgroup analyses (e.g., active versus
remitted cancer) revealed differential findings, suggesting the existence of group differences.
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However, such differences are supported by the extant literature on self-compassion (Neff,
2003), perceived control and HRQL (Ramsey et al., 2002; Richardson, Morton, & Broadbent,
2016). Furthermore, our constructs of interest may manifest differently across disease
populations, potentially yielding different patterns of results. For instance, among persons living
with fibromyalgia, stigma regarding etiology may pose barriers to engaging in self-compassion
or achievement of perceived control (Kool, van Middendorp, Roeije, & Geenen, 2009), and the
waxing and waning of symptoms (e.g., pain, fatigue) may contribute to lack of perceived control
and changes in HRQL (Arnold et al., 2008).
Next, our use of cross-sectional data precludes the examination of causality, and bidirectionality of variables is a possibility. As but one example, poor health functioning, including
physical impairments, may contribute to a perceived loss of control among cancer patients and
survivors, with symptoms or functional limitations viewed as “evidence” of loss of control over
health (Norton et al., 2005). Future studies, using diverse samples, including other illness groups,
and employing alternative research designs, are needed to substantiate our findings, and to
clarify the manifestations of, and interrelations between, our study variables
A third limitation is our use of self-report measures, with their potential for various types
of respondent bias. Social desirability is one consideration; for instance, respondents may have
overreported treatment adherence, to avoid embarrassment or shame associated with
noncompliance (Stirratt et al., 2015). Medical professionals and individuals in the cancer
population may also have different standards of what it means to be “adherent” (Horne et al.,
2005). Given the subjectivity of self-report measures, it is also difficult to know what unassessed
factors (e.g., personal values, specific symptoms) influenced ratings of physical HRQL across
participants (Cella & Stone, 2015; Wilson & Clearly, 1995). Yet another consideration is that
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online administration of self-report measures does not permit clarification or explanation in cases
of participant confusion, and the extent to which participants understood the meaning of
questions or response options remains unknown (Demetriou, Ozer, & Essau, 2015).
Future research, replicating our serial mediation models, could use alternative forms of
measurement for study variables. Biomarkers (e.g., heart rate) may be used as measures of the
effectiveness of self-compassion interventions and therapies, providing an indication of
reductions in negative emotional states (e.g., stress, anxiety) and increases in positive affect (e.g.,
happiness; Sirois & Rowse, 2016). Alternative measures of treatment adherence may also be
desirable, such as physiological indicators (e.g., blood draws), a review of pharmacy or medical
records, and even proxy reports from health care providers and family members (Atkins &
Fallowfield, 2006; Martin et al., 2005). Focus groups or in-person interviews at cancer treatment
centers or survivorship support groups would also be desirable in order to gather additional
details from participants regarding their illness experiences. At present, some researchers have
taken this approach (O’Hea et al., 2005; Ussher et al., 2006; van Uden-Kraan et al., 2008) to
their study design, albeit none have examined all of the present study’s variables within a single
context or integrated qualitative and quantitative data for all of these variables within the cancer
population specifically.
Yet another limitation is our exclusive focus on physical HRQL and lack of significant
findings across many analyses. Limited examination of constructs may have contributed to our
null findings, especially given the prevalence of mental health problems (e.g., anxiety,
depression) experienced by those with cancer and the extent to which psychopathology
influences illness perspectives and health behaviors (Magai et al., 2007; Theofilou &
Panagiotaki, 2012). In future research, it will be important to include measures of both mental
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(e.g., emotional distress) and physical (e.g., illness symptoms, role limitations) HRQL, and to
assess their interrelations, to provide clarification on the cognitive-emotional and mind-body
functioning of persons enduring the experience of cancer.
Other disease (e.g., co-morbidities, recurrent diagnosis) or treatment characteristics (e.g.,
complexity, cost), which were not assessed in the present study, may have also influenced
patterns of results, especially among those living with a current diagnosis (Bender et al., 2014;
Denois et al., 2011; Dimatteo et al., 1992; Patridge et al., 2002). Future research would benefit
from advanced assessment of disease and treatment histories, to guide hypotheses; for example,
classifying patients into alternative diagnostic categories (e.g., first diagnosis compared to
recurrent cancer) may yield novel clinical insights about the effects of our study variables as they
occur within different manifestations of the disease. Use of qualitative techniques, such as openended questions and in-person interviews, could also be utilized, to gain a subjective and patientcentered reporting of factors influencing engagement in treatment and successful control and
coping with illness.
Furthermore, both the significant and nonsignificant findings of our study should be
interpreted with caution, due to our small sample size and the possibility of low statistical power
to detect effects. Bootstrapping, which is a resampling strategy, was utilized to account for this
potential limitation (Preacher & Hayes, 2008). In future research, utilization of alternative
software programs (e.g., R Studio) or advanced sample size planning analyses (e.g., Monte Carlo
simulation) can help to insure recruitment of a sample large enough to obtain adequate statistical
power (Anderson, Kelley, & Maxwell, 2017).
Another area to be targeted in future research, is the development of self-compassion
interventions tailored specifically for persons in the cancer population, with acknowledgement of
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their unique experiences (e.g., self-blame for diagnosis) and the difficulties they may encounter
while engaging in traditional mindfulness activities, such as pain interference in progressive
muscle relaxation or psychological avoidance of cancer sites during body scan exercises (Foley
et al., 2010). At present, very few existing self-compassion interventions have been tested among
persons in the cancer population (Kirby, 2017); however, given our findings, and those from
previous studies, indicating a beneficial relation between self-compassion and HRQL, additional
clinical research is warranted.
As well, we could find no intervention studies which examined the enhancement of selfefficacy and perceived control as a means of altering rates of adherence to specific WHO (2003)
guidelines for the cancer population. By developing interventions which align with these
recommendations, it may be possible to overcome some of the current barriers to treatment
adherence among persons in the cancer population (Denois et al., 2011; Patridge et al., 2002;
Puts et al., 2014; Theofilou & Panagiotaki, 2012), with implications for physical HRQL.
Despite such limitations and the need for continued scientific exploration, our study
represents an important first step toward an enhanced understanding of the associations between
self-compassion, control beliefs, treatment adherence, and HRQL in a vulnerable sample. With
advancements in patient-centered research as predictors of health outcomes, and a growing body
of evidence regarding the therapeutic promotion of resiliency traits, researchers and clinicians
may be able to address the uncertainty and fears associated with cancer, thereby promoting better
subjective health throughout the illness experience.
Conclusion
Our findings illustrate the positive direct effects of self-compassion on physical HRQL
among persons living with a past or present cancer diagnosis. As well, our study lends support to
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the role of control beliefs as a mediator of this association, and highlights the importance of
treatment adherence for health status in the cancer population.
In our overall sample, including those with a current diagnosis and remitted cancer,
perceived illness/health control emerged as a significant mediator of the relation between selfcompassion and physical HRQL. In our subsamples, a similar pattern of results was obtained for
persons with remitted cancer, but no mediating effects were found for persons with a current
cancer diagnosis. This pattern of differential findings across diagnostic groups draws attention to
the circumstantial nature and impact of individual-level resiliency characteristics on health
functioning and quality of life. Disease status may influence the degree to which one can draw
upon self-compassion elements or a sense of control, with consequences for engagement in
health behaviors and perceptions of health.
Yet, with the exception of one model (out of 24), treatment adherence did not emerge as a
significant mediator of the relation between self-compassion and physical HRQL but, at the
bivariate level, was positively associated with self-compassion, control beliefs, and perceptions
of health. Our findings suggest that, while treatment adherence is important for health, other
factors likely play a role in the linkage between self-compassion and HRQL. Given that the
trajectory of cancer is often tenuous, adherence to a healthcare provider’s recommendations does
not guarantee perceptions of good health status and, therefore, there is a need to identify
additional psychosocial or treatment-related factors that can be leveraged to improve patientcentered health ratings.
Finally, the absence of any significant serial mediation models highlights the need for
additional research on the association of self-compassion, control beliefs, treatment adherence,
and physical HRQL in the cancer population. In the future, research with diverse samples and
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prospective, longitudinal research designs, is necessary, and which includes multi-method
assessment approaches (e.g., interview-based, biomarkers) of a wider array of potential
contributing factors, including psychopathology and characteristics of one’s disease and
treatment.
Nonetheless, our study is an important first step toward understanding the mechanisms
involved in the linkage of self-compassion and physical HRQL in a vulnerable, medical
population. Additionally, our findings can begin to inform clinical work with cancer patients and
survivors, as they indicate, broadly, that subjective health may benefit from interventions which
foster a sense of self-compassion, perceptions of control over illness, and motivation to adhere to
the recommendations of healthcare providers.
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